<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Microorganisms</journal-id>
<journal-id journal-id-type="iso-abbrev">Microorganisms</journal-id>
<journal-id journal-id-type="publisher-id">microorganisms</journal-id>
<journal-title-group>
<journal-title>Microorganisms</journal-title>
</journal-title-group>
<issn pub-type="epub">2076-2607</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31623187</article-id>
<article-id pub-id-type="pmc">6843596</article-id>
<article-id pub-id-type="doi">10.3390/microorganisms7100459</article-id>
<article-id pub-id-type="publisher-id">microorganisms-07-00459</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pathogenetic Impact of Bacterial–Fungal Interactions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nogueira</surname>
<given-names>Filomena</given-names>
</name>
<xref ref-type="aff" rid="af1-microorganisms-07-00459">1</xref>
<xref ref-type="aff" rid="af2-microorganisms-07-00459">2</xref>
<xref ref-type="aff" rid="af3-microorganisms-07-00459">3</xref>
<xref ref-type="corresp" rid="c1-microorganisms-07-00459">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharghi</surname>
<given-names>Shirin</given-names>
</name>
<xref ref-type="aff" rid="af1-microorganisms-07-00459">1</xref>
<xref ref-type="aff" rid="af2-microorganisms-07-00459">2</xref>
<xref ref-type="aff" rid="af3-microorganisms-07-00459">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2719-5955</contrib-id>
<name>
<surname>Kuchler</surname>
<given-names>Karl</given-names>
</name>
<xref ref-type="aff" rid="af3-microorganisms-07-00459">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lion</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="af1-microorganisms-07-00459">1</xref>
<xref ref-type="aff" rid="af2-microorganisms-07-00459">2</xref>
<xref ref-type="aff" rid="af4-microorganisms-07-00459">4</xref>
<xref ref-type="corresp" rid="c1-microorganisms-07-00459">*</xref>
</contrib>
</contrib-group>
<aff id="af1-microorganisms-07-00459"><label>1</label>CCRI—St. Anna Children’s Cancer Research Institute, Vienna 1090, Austria; <email>shirin.sharghi@ccri.at</email></aff>
<aff id="af2-microorganisms-07-00459"><label>2</label>Labdia—Labordiagnostik GmbH, Vienna 1090, Austria</aff>
<aff id="af3-microorganisms-07-00459"><label>3</label>Center of Medical Biochemistry, Max Perutz Labs, Campus Vienna Biocenter, Medical University of Vienna, Vienna 1030, Austria; <email>karl.kuchler@meduniwien.ac.at</email></aff>
<aff id="af4-microorganisms-07-00459"><label>4</label>Department of Pediatrics, Medical University of Vienna, Vienna 1090, Austria</aff>
<author-notes>
<corresp id="c1-microorganisms-07-00459"><label>*</label>Correspondence: <email>filomena.nogueira@ccri.at</email> (F.N.); <email>thomas.lion@ccri.at</email> (T.L.); Tel.: +43-1-40-470-4890 (F.N.&amp;T.L.)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2019</year>
</pub-date>
<volume>7</volume>
<issue>10</issue>
<elocation-id>459</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Polymicrobial infections are of paramount importance because of the potential severity of clinical manifestations, often associated with increased resistance to antimicrobial treatment. The intricate interplay with the host and the immune system, and the impact on microbiome imbalance, are of importance in this context. The equilibrium of microbiota in the human host is critical for preventing potential dysbiosis and the ensuing development of disease. Bacteria and fungi can communicate via signaling molecules, and produce metabolites and toxins capable of modulating the immune response or altering the efficacy of treatment. Most of the bacterial–fungal interactions described to date focus on the human fungal pathogen <italic>Candida albicans</italic> and different bacteria. In this review, we discuss more than twenty different bacterial–fungal interactions involving several clinically important human pathogens. The interactions, which can be synergistic or antagonistic, both <italic>in vitro</italic> and <italic>in vivo</italic>, are addressed with a focus on the quorum-sensing molecules produced, the response of the immune system, and the impact on clinical outcome.</p>
</abstract>
<kwd-group>
<kwd>bacterial–fungal interactions</kwd>
<kwd>microbiome</kwd>
<kwd>molecules</kwd>
<kwd>immune response</kwd>
<kwd><italic>in vivo</italic> models</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-microorganisms-07-00459" sec-type="intro">
<title>1. Introduction</title>
<p>Identification and subsequent exploitation of the mechanisms that mediate communication between bacteria and fungi, as well as the interplay with the host and the immune system, can provide the basis for the discovery of novel biomarkers facilitating improved diagnostics and more effective treatment approaches. <italic>In vivo</italic> models are required for clinically relevant understanding of bacterial–fungal interactions (BFI), as currently available <italic>in vitro</italic> assays may not reflect the implications in the affected host. In some instances, the findings of BFI were even completely discrepant between different experimental settings by revealing antagonistic interactions <italic>in vitro</italic> and synergistic effects in <italic>in vivo</italic> models, presenting with increased virulence and pathogenicity in the host [<xref ref-type="bibr" rid="B1-microorganisms-07-00459">1</xref>,<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>]. Current diagnostic approaches are not designed to routinely assess polymicrobial infections, and may therefore miss the presence of bacterial–fungal co-infections. In instances in which the co-infection results in one-way or mutual inhibitory interactions, treatment with antibiotics or antifungals may therefore promote or unleash growth of the microbiota not covered by the antimicrobial therapy, with possible implications for morbidity and mortality. Studies have shown that mixed cultures of <italic>Candida</italic> and bacteria occur in about 23% of the reported episodes of candidemia, with a predominance of <italic>Staphylococci</italic> in these associations [<xref ref-type="bibr" rid="B3-microorganisms-07-00459">3</xref>]. However, no significant differences in the clinical outcome of patients with mixed bloodstream infections were observed in comparison to monomicrobial candidemia. Prior use of antibiotics was associated with decreased prevalence of mixed <italic>Candida</italic>–bacterial bloodstream infections [<xref ref-type="bibr" rid="B3-microorganisms-07-00459">3</xref>]. The clinical implications of bacterial–fungal interactions are reviewed in [<xref ref-type="bibr" rid="B4-microorganisms-07-00459">4</xref>,<xref ref-type="bibr" rid="B5-microorganisms-07-00459">5</xref>,<xref ref-type="bibr" rid="B6-microorganisms-07-00459">6</xref>,<xref ref-type="bibr" rid="B7-microorganisms-07-00459">7</xref>], and there is evidence that some BFI can promote disease [<xref ref-type="bibr" rid="B8-microorganisms-07-00459">8</xref>]. Associations between <italic>Candida</italic> and <italic>Enterobacter</italic> have been detected in all types of clinical specimens investigated and, in most cases, the frequency of these associations was statistically significant. Co-isolation of <italic>Enterococcus faecalis</italic> and fungi was reported in 22% of patients treated in intensive care units, and other bacteria frequently co-isolated with fungi included the genera <italic>Klebsiella</italic> and <italic>Serratia</italic> [<xref ref-type="bibr" rid="B7-microorganisms-07-00459">7</xref>]. Co-infections by <italic>Candida</italic> and the bacteria <italic>Enterobacter</italic>, <italic>Klebsiella</italic>, or <italic>Serratia</italic> have led to increased rates of hospitalization [<xref ref-type="bibr" rid="B3-microorganisms-07-00459">3</xref>,<xref ref-type="bibr" rid="B7-microorganisms-07-00459">7</xref>]. Another study showed that a significant proportion of candidemias occurred in parallel with bacteremia, although no significant differences in long-term survival were observed between single and co-infections [<xref ref-type="bibr" rid="B3-microorganisms-07-00459">3</xref>]. Kett and colleagues have shown that 38% of patients testing positive for <italic>Candida</italic> infection had a co-infection with bacteria [<xref ref-type="bibr" rid="B9-microorganisms-07-00459">9</xref>]. Similarly, postmortem blood analysis showed mixed infections by <italic>Candida</italic> and bacteria in 39% of the cases investigated [<xref ref-type="bibr" rid="B10-microorganisms-07-00459">10</xref>].</p>
<p>Communication between bacteria and fungi is mediated via quorum sensing molecules and proteins [<xref ref-type="bibr" rid="B11-microorganisms-07-00459">11</xref>,<xref ref-type="bibr" rid="B12-microorganisms-07-00459">12</xref>,<xref ref-type="bibr" rid="B13-microorganisms-07-00459">13</xref>]. Identification of these signalling molecules and assessing their interplay with the immune system, e.g., by determining specific cytokine profiles, renders them an attractive target for more specific diagnostics and treatment. Recent studies have identified a set of signaling molecules secreted by human intestinal microbiota that accumulate at detectable concentrations, and have suggested that these molecules could be used as markers of disease (reviewed in [<xref ref-type="bibr" rid="B14-microorganisms-07-00459">14</xref>]). Microbial and, specifically, bacterial–fungal interactions, can also result in the production of molecules potentially affecting host homeostasis. Moreover, recent insights derived from metagenomic and metabolomic analyses indicate that the integration of multifaceted data can provide the basis for improved therapies [<xref ref-type="bibr" rid="B15-microorganisms-07-00459">15</xref>,<xref ref-type="bibr" rid="B16-microorganisms-07-00459">16</xref>]. Krüger and colleagues have described fungal–bacterial interactions with a focus on the mucosal niches and consequences for the human host [<xref ref-type="bibr" rid="B17-microorganisms-07-00459">17</xref>]. In the present review, we focus on describing the spectrum of BFI identified to date, with potential relevance for the human host. The focus is placed on the mechanisms of intermicrobial communication, including the respective metabolites involved and the interplay with the host immune system, addressing the cytokine and chemokine profile of BFI.</p>
</sec>
<sec id="sec2-microorganisms-07-00459">
<title>2. Bacterial–Fungal Interactions in the Context of the Microbiome</title>
<p>Microbial interactions are an integral part of the highly complex human microbiome. Mapping of the human microbiome has shown a wide diversity of bacteria and fungi occupying specific niches [<xref ref-type="bibr" rid="B18-microorganisms-07-00459">18</xref>,<xref ref-type="bibr" rid="B19-microorganisms-07-00459">19</xref>,<xref ref-type="bibr" rid="B20-microorganisms-07-00459">20</xref>,<xref ref-type="bibr" rid="B21-microorganisms-07-00459">21</xref>]. Whereas most studies have focused primarily on the bacteriome, the realms of fungi and viruses, the mycobiome and virome, have been studied less extensively. The human intestinal mycobiome has a considerably lower diversity compared to the bacteriome. The dominant genera in a healthy individual include <italic>Saccharomyces, Malassezia</italic>, and <italic>Candida</italic> [<xref ref-type="bibr" rid="B19-microorganisms-07-00459">19</xref>]. Microbes may have beneficial, neutral, or harmful effects while interacting with the host and the immune system. The microbiota play a key role in host homeostasis, including the regulation of the immune system and production of essential vitamins, amino acids, metabolites, and byproducts necessary for the normal function of many processes [<xref ref-type="bibr" rid="B22-microorganisms-07-00459">22</xref>,<xref ref-type="bibr" rid="B23-microorganisms-07-00459">23</xref>,<xref ref-type="bibr" rid="B24-microorganisms-07-00459">24</xref>,<xref ref-type="bibr" rid="B25-microorganisms-07-00459">25</xref>,<xref ref-type="bibr" rid="B26-microorganisms-07-00459">26</xref>,<xref ref-type="bibr" rid="B27-microorganisms-07-00459">27</xref>]. Intestinal microbiota also protect against colonization by pathogenic microorganisms.</p>
<p>However, once the equilibrium of the microbiota is disturbed, e.g., by a variety of conditions or alterations, including diet, treatment with antibiotics or other drugs, age, stress, chronic inflammation, or various underlying diseases, shifts in the levels and composition will occur, with consequences for the onset and progression of disease [<xref ref-type="bibr" rid="B18-microorganisms-07-00459">18</xref>,<xref ref-type="bibr" rid="B26-microorganisms-07-00459">26</xref>,<xref ref-type="bibr" rid="B27-microorganisms-07-00459">27</xref>,<xref ref-type="bibr" rid="B28-microorganisms-07-00459">28</xref>]. Variations in the intestinal microflora have been helpful in establishing differences between the states of health and disease [<xref ref-type="bibr" rid="B16-microorganisms-07-00459">16</xref>,<xref ref-type="bibr" rid="B18-microorganisms-07-00459">18</xref>,<xref ref-type="bibr" rid="B20-microorganisms-07-00459">20</xref>,<xref ref-type="bibr" rid="B29-microorganisms-07-00459">29</xref>,<xref ref-type="bibr" rid="B30-microorganisms-07-00459">30</xref>,<xref ref-type="bibr" rid="B31-microorganisms-07-00459">31</xref>,<xref ref-type="bibr" rid="B32-microorganisms-07-00459">32</xref>,<xref ref-type="bibr" rid="B33-microorganisms-07-00459">33</xref>,<xref ref-type="bibr" rid="B34-microorganisms-07-00459">34</xref>,<xref ref-type="bibr" rid="B35-microorganisms-07-00459">35</xref>,<xref ref-type="bibr" rid="B36-microorganisms-07-00459">36</xref>,<xref ref-type="bibr" rid="B37-microorganisms-07-00459">37</xref>,<xref ref-type="bibr" rid="B38-microorganisms-07-00459">38</xref>,<xref ref-type="bibr" rid="B39-microorganisms-07-00459">39</xref>].</p>
<p>Experimental approaches addressing the microbiome have been based on the use of completely germ-free (gnotobiotic) mice to assess the impact of an altered microbiome from diseased mice transplanted into these animals [<xref ref-type="bibr" rid="B40-microorganisms-07-00459">40</xref>,<xref ref-type="bibr" rid="B41-microorganisms-07-00459">41</xref>,<xref ref-type="bibr" rid="B42-microorganisms-07-00459">42</xref>]. It was shown that the disease-associated microbiome is commonly adopted by the gnotobiotic mice, facilitating studies on the role of specific microbes and their composition on metabolic and immune processes [<xref ref-type="bibr" rid="B43-microorganisms-07-00459">43</xref>,<xref ref-type="bibr" rid="B44-microorganisms-07-00459">44</xref>,<xref ref-type="bibr" rid="B45-microorganisms-07-00459">45</xref>,<xref ref-type="bibr" rid="B46-microorganisms-07-00459">46</xref>,<xref ref-type="bibr" rid="B47-microorganisms-07-00459">47</xref>]. Such studies in mouse models have contributed to improved understanding of the influence of an imbalanced microbiome on the health status, and have set the stage for studies addressing the complex microbial interactions occurring in the human host. Bacteria and fungi often live in organized structures, termed biofilms, rather than in planktonic state. The formation of either intra-domain (bacterial–bacterial or fungal–fungal) or inter-domain (bacterial–fungal) interactions within biofilms have been implicated in a variety of diseases, such as cystic fibrosis (e.g., interactions between <italic>Inquilinus limosus</italic>, <italic>Dolosigranulum pigrum</italic>, <italic>Burkholderia cepacia</italic> and <italic>Pseudomonas aeruginosa</italic>), endocarditis, prostatitis, and cancer [<xref ref-type="bibr" rid="B48-microorganisms-07-00459">48</xref>,<xref ref-type="bibr" rid="B49-microorganisms-07-00459">49</xref>]. Bacterial biofilms have been suggested to play a role in the progression of colorectal cancer (CRC) [<xref ref-type="bibr" rid="B50-microorganisms-07-00459">50</xref>], and polymicrobial, i.e., bacterial–fungal co-infections (e.g., interactions between <italic>Candida albicans</italic>, <italic>Aspergillus fumigatus</italic>, and <italic>P. aeruginosa</italic>) were shown to display more deleterious effects in the context of cystic fibrosis compared to single pathogen infections [<xref ref-type="bibr" rid="B51-microorganisms-07-00459">51</xref>,<xref ref-type="bibr" rid="B52-microorganisms-07-00459">52</xref>,<xref ref-type="bibr" rid="B53-microorganisms-07-00459">53</xref>]. Similarly, the fungal genera <italic>Candida</italic> and <italic>Rhodotorula</italic> have been linked to atopic diseases, including asthma in infants [<xref ref-type="bibr" rid="B54-microorganisms-07-00459">54</xref>,<xref ref-type="bibr" rid="B55-microorganisms-07-00459">55</xref>]. By contrast, certain bacterial–fungal interactions, such as those of various <italic>Candida</italic> species and <italic>Lactobacilli,</italic> which are part of the normal vulvovaginal microflora, were demonstrated to be beneficial for the host by preventing candidiasis at this site [<xref ref-type="bibr" rid="B56-microorganisms-07-00459">56</xref>,<xref ref-type="bibr" rid="B57-microorganisms-07-00459">57</xref>]. Moreover, <italic>Candida</italic> is also thought to prevent life-threatening urinary tract infections by <italic>Escherichia coli</italic> [<xref ref-type="bibr" rid="B58-microorganisms-07-00459">58</xref>,<xref ref-type="bibr" rid="B59-microorganisms-07-00459">59</xref>,<xref ref-type="bibr" rid="B60-microorganisms-07-00459">60</xref>].</p>
<sec id="sec2dot1-microorganisms-07-00459">
<title>2.1. Impact of Microbiome Dysbiosis on the Bacterial–Fungal Equilibrium</title>
<p>Dysbiosis is characterized by changes in the amount, composition, distribution, function, and metabolic activity of physiological microbiota. It is associated with loss of biodiversity and overgrowth of pathogenic species [<xref ref-type="bibr" rid="B39-microorganisms-07-00459">39</xref>]. A variety of very diverse diseases have been associated with dysbiosis, including inflammatory bowel disease, obesity, allergy, diabetes, autism, and colorectal cancer, where dysbiosis can either be a causal factor or a secondary effect of the disease [<xref ref-type="bibr" rid="B39-microorganisms-07-00459">39</xref>]. Bacterial dysbiosis, displaying the prevalence of completely different types of bacteria in comparison to healthy lungs, has been described in chronic lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis [<xref ref-type="bibr" rid="B18-microorganisms-07-00459">18</xref>]. In Crohn´s disease (CD), dysbiosis with increased levels of Proteobacteria, Fusobacteria, and the fungal species <italic>C. albicans</italic> and <italic>Candida glabrata</italic>, has been described during disease progression [<xref ref-type="bibr" rid="B36-microorganisms-07-00459">36</xref>,<xref ref-type="bibr" rid="B61-microorganisms-07-00459">61</xref>]. Moreover, commensal fungi such as <italic>Saccharomyces cerevisiae</italic> may also display harmful effects during dysbiosis by inducing damage of the intestinal barrier [<xref ref-type="bibr" rid="B62-microorganisms-07-00459">62</xref>]. Antibiotic or antifungal treatment may have implications for the balance and the interactions between bacteria and fungi. For example, depletion of commensal intestinal fungi may unleash the growth of bacteria with pathogenic potential, leading to an exacerbation of colitis [<xref ref-type="bibr" rid="B63-microorganisms-07-00459">63</xref>]. Colonization with <italic>C. albicans</italic> in mice treated with antibiotics was shown to increase allergic airway disease [<xref ref-type="bibr" rid="B64-microorganisms-07-00459">64</xref>], but antifungal treatment was also reported to mediate a similar clinical effect [<xref ref-type="bibr" rid="B65-microorganisms-07-00459">65</xref>]. Hence, in various states of dysbiosis, loss of the bacterial–fungal equilibrium and corresponding interactions can play a pathogenetic role in different diseases.</p>
</sec>
<sec id="sec2dot2-microorganisms-07-00459">
<title>2.2. Microbial Metabolites—the Good and the Bad</title>
<p>Intestinal microbes can communicate with the host via microbial metabolites, which may mediate beneficial or harmful effects [<xref ref-type="bibr" rid="B66-microorganisms-07-00459">66</xref>]. The host benefits from microbiota owing to their production of certain amino acids and vitamins [<xref ref-type="bibr" rid="B25-microorganisms-07-00459">25</xref>,<xref ref-type="bibr" rid="B67-microorganisms-07-00459">67</xref>], and commensal microbes also produce a range of small molecules inhibiting the growth of pathogenic microorganisms. For example, specific intestinal bacteria such as Firmicutes produce short-chain fatty acids (SCFA), including butyrate, acetate, and propionate, through the fermentation of fibers and other polysaccharide compounds, which have an important role in immune development, control of inflammation, and defense against infection [<xref ref-type="bibr" rid="B68-microorganisms-07-00459">68</xref>]. Butyrate is also used as an energy source for intestinal epithelial cells, thereby conferring protection against pathogens [<xref ref-type="bibr" rid="B69-microorganisms-07-00459">69</xref>]. Butyric acid also inhibits the yeast-to-hyphal transition of <italic>C. albicans</italic>, a key virulence attribute of this opportunistic pathogen [<xref ref-type="bibr" rid="B70-microorganisms-07-00459">70</xref>], and several studies have associated butyrate with protective effects against infectious diseases. However, the net effect of a microbial metabolite can depend on the specific environmental conditions. Butyrate was shown to display protective effects against colorectal cancer (CRC), but a decrease in the butyrate-producing bacteria Firmicutes was described in inflammatory bowel disease (IBD), thus potentially compromising the beneficial effect of this SCFA [<xref ref-type="bibr" rid="B71-microorganisms-07-00459">71</xref>,<xref ref-type="bibr" rid="B72-microorganisms-07-00459">72</xref>]. However, other studies performed in a murine model described butyrate as promoting carcinogenesis by enhancing epithelial cell proliferation [<xref ref-type="bibr" rid="B73-microorganisms-07-00459">73</xref>]. The controversial effects of butyrate are well documented [<xref ref-type="bibr" rid="B74-microorganisms-07-00459">74</xref>]. Other examples of harmful metabolites include alanine and lactate, which are present in the lungs of cystic fibrosis patients, and promote the growth of <italic>P. aeruginosa</italic> [<xref ref-type="bibr" rid="B75-microorganisms-07-00459">75</xref>]. Furthermore, phenolic compounds, amines, ammonia, acetaldehyde, nitrosamines, and sulphides are microbial metabolites generated by protein fermentation, which have been shown to be toxic for the host (e.g., by impairing metabolic functions or by mediating DNA damage), and also promoting of cancer development [<xref ref-type="bibr" rid="B35-microorganisms-07-00459">35</xref>,<xref ref-type="bibr" rid="B38-microorganisms-07-00459">38</xref>,<xref ref-type="bibr" rid="B76-microorganisms-07-00459">76</xref>,<xref ref-type="bibr" rid="B77-microorganisms-07-00459">77</xref>]. Production of such toxins in the intestinal tract is mediated by quorum sensing communication among different microbial species [<xref ref-type="bibr" rid="B28-microorganisms-07-00459">28</xref>].</p>
</sec>
</sec>
<sec id="sec3-microorganisms-07-00459">
<title>3. Communication between Bacteria and Fungi Mediated by Proteins and Small Molecules</title>
<p>Microbial interactions are mediated by several mechanisms that also serve as virulence factors, including quorum sensing, biofilm formation, production of secondary metabolites, and cellular signal transduction [<xref ref-type="bibr" rid="B78-microorganisms-07-00459">78</xref>,<xref ref-type="bibr" rid="B79-microorganisms-07-00459">79</xref>,<xref ref-type="bibr" rid="B80-microorganisms-07-00459">80</xref>,<xref ref-type="bibr" rid="B81-microorganisms-07-00459">81</xref>,<xref ref-type="bibr" rid="B82-microorganisms-07-00459">82</xref>,<xref ref-type="bibr" rid="B83-microorganisms-07-00459">83</xref>]. Such interactions can be quite complex, and occur particularly when different microorganisms share the same niches in the host, resulting in differential effects that can be antagonistic, synergistic, or neutral. Hence, bacteria and fungi can mutually support their growth or exert competitive effects, potentially leading to suppression of one microorganism and dominant growth of the other. Suppressive and inhibitory interactions mediated by different molecules or factors can occur simultaneously, depending on specific stimuli and changes in the microenvironment (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>). Several studies have demonstrated that polymicrobial infections can be more severe and result in considerably higher mortality than infections with single pathogens, as reported, for example, for co-infections with <italic>A. fumigatus</italic> and <italic>P. aeruginosa</italic> or with <italic>C. albicans</italic> and <italic>P. aeruginosa</italic> in certain clinical settings [<xref ref-type="bibr" rid="B1-microorganisms-07-00459">1</xref>,<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>,<xref ref-type="bibr" rid="B51-microorganisms-07-00459">51</xref>,<xref ref-type="bibr" rid="B52-microorganisms-07-00459">52</xref>,<xref ref-type="bibr" rid="B53-microorganisms-07-00459">53</xref>,<xref ref-type="bibr" rid="B84-microorganisms-07-00459">84</xref>,<xref ref-type="bibr" rid="B85-microorganisms-07-00459">85</xref>,<xref ref-type="bibr" rid="B86-microorganisms-07-00459">86</xref>]. New therapeutic strategies targeting quorum sensing molecules and bacterial virulence factors are being tested with the aim to deliver more efficient antimicrobial treatment and to prevent development of drug resistance [<xref ref-type="bibr" rid="B87-microorganisms-07-00459">87</xref>,<xref ref-type="bibr" rid="B88-microorganisms-07-00459">88</xref>,<xref ref-type="bibr" rid="B89-microorganisms-07-00459">89</xref>,<xref ref-type="bibr" rid="B90-microorganisms-07-00459">90</xref>,<xref ref-type="bibr" rid="B91-microorganisms-07-00459">91</xref>]. Such approaches were tested specifically against infections with <italic>P. aeruginosa</italic> and were able to disrupt the cell communication and to reduce the virulence [<xref ref-type="bibr" rid="B92-microorganisms-07-00459">92</xref>,<xref ref-type="bibr" rid="B93-microorganisms-07-00459">93</xref>,<xref ref-type="bibr" rid="B94-microorganisms-07-00459">94</xref>,<xref ref-type="bibr" rid="B95-microorganisms-07-00459">95</xref>]. Other studies have attempted to use antibiotics and antifungals in combination with quorum sensing molecules to treat bacterial–fungal infections [<xref ref-type="bibr" rid="B96-microorganisms-07-00459">96</xref>]. For example, the quorum sensing molecule farnesol, which inhibits filamentation of <italic>C. albicans</italic>, [<xref ref-type="bibr" rid="B97-microorganisms-07-00459">97</xref>] has been tested in combination with antifungal drugs, and resulted in decreased minimal inhibitory concentration (MIC) values [<xref ref-type="bibr" rid="B98-microorganisms-07-00459">98</xref>].</p>
<p>The bacterial–fungal interactions described to date mainly involve the interplay of <italic>C. albicans</italic> with different bacterial species. Exploitation of the growing knowledge of the microbiome offers new insights into the diversity of bacterial and fungal species colonizing the human body, many of which share the same niches. This information, along with pertinent clinical studies, unravels microbial interactions of potential clinical relevance. Here, we describe the mechanisms involved in various bacterial–fungal interactions in the human host, with a focus on quorum sensing molecules and virulence factors.</p>
<sec id="sec3dot1-microorganisms-07-00459">
<title>3.1. Bacterial–Fungal Interactions</title>
<sec id="sec3dot1dot1-microorganisms-07-00459">
<title>3.1.1. <italic>Candida</italic> Species and Different Bacteria</title>
<p><italic>Candida albicans</italic> and <italic>Pseudomonas aeruginosa</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): This bacterial–fungal interaction is one of the most widely studied microbial interplays. Well documented examples of sites revealing an interplay between these pathogens include intravenous catheters, lungs of cystic fibrosis patients, the respiratory tract of ventilated patients, and burn wounds [<xref ref-type="bibr" rid="B11-microorganisms-07-00459">11</xref>]. The interaction between <italic>C. albicans</italic> and <italic>P. aeruginosa</italic>, which is mediated by the production of quorum sensing molecules and virulence factors, is rather complex, as synergistic and antagonistic effects can occur simultaneously [<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>,<xref ref-type="bibr" rid="B86-microorganisms-07-00459">86</xref>,<xref ref-type="bibr" rid="B99-microorganisms-07-00459">99</xref>,<xref ref-type="bibr" rid="B100-microorganisms-07-00459">100</xref>,<xref ref-type="bibr" rid="B101-microorganisms-07-00459">101</xref>,<xref ref-type="bibr" rid="B102-microorganisms-07-00459">102</xref>,<xref ref-type="bibr" rid="B103-microorganisms-07-00459">103</xref>,<xref ref-type="bibr" rid="B104-microorganisms-07-00459">104</xref>]. <italic>P. aeruginosa</italic> produces phenazines, including pyocyanin as a toxic end product, decanol, and 3-oxo-C12-homoserine lactone (3OC<sub>12</sub>HSL), which inhibit <italic>C. albicans</italic> biofilm formation and hyphal development via generation of highly toxic reactive oxygen species (ROS) [<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>,<xref ref-type="bibr" rid="B86-microorganisms-07-00459">86</xref>,<xref ref-type="bibr" rid="B99-microorganisms-07-00459">99</xref>,<xref ref-type="bibr" rid="B100-microorganisms-07-00459">100</xref>,<xref ref-type="bibr" rid="B101-microorganisms-07-00459">101</xref>,<xref ref-type="bibr" rid="B102-microorganisms-07-00459">102</xref>,<xref ref-type="bibr" rid="B103-microorganisms-07-00459">103</xref>,<xref ref-type="bibr" rid="B105-microorganisms-07-00459">105</xref>,<xref ref-type="bibr" rid="B106-microorganisms-07-00459">106</xref>]. Interestingly, the concentrations of homoserine lactone (HSL) were considerably higher in biofilms than in the presence of these microbes in planktonic state [<xref ref-type="bibr" rid="B107-microorganisms-07-00459">107</xref>]. Additional molecules produced by <italic>P. aeruginosa</italic> include hemolytic phospholipase C and other virulence factors, such as GacA, LasR, RhlR, and RpoN [<xref ref-type="bibr" rid="B108-microorganisms-07-00459">108</xref>]. The capacity of <italic>P. aeruginosa</italic> to adhere to the hyphal form of <italic>C. albicans</italic> is 30 times higher than binding to the yeast form, resulting in condition-dependent killing of hyphae [<xref ref-type="bibr" rid="B84-microorganisms-07-00459">84</xref>,<xref ref-type="bibr" rid="B108-microorganisms-07-00459">108</xref>]. In addition to secreting inhibitory molecules, <italic>P. aeruginosa</italic> can also increase the virulence of <italic>C. albicans</italic> by producing the proteolytic enzyme elastase (LasB), thus underscoring the differential effects mediated by <italic>P. aeruginosa</italic> in this interaction [<xref ref-type="bibr" rid="B100-microorganisms-07-00459">100</xref>]. Conversely, farnesol, a quorum-sensing molecule produced by <italic>C. albicans,</italic> can downregulate the quorum sensing system of <italic>P. aeruginosa</italic> by affecting the production of pyocyanin and reducing bacterial motility [<xref ref-type="bibr" rid="B109-microorganisms-07-00459">109</xref>]. To the advantage of <italic>P. aeruginosa</italic>, generation of fermented products by <italic>C. albicans</italic> enhances the phenazine secretion by <italic>P. aeruginosa,</italic> thus promoting colonization of the lungs by the bacterium [<xref ref-type="bibr" rid="B110-microorganisms-07-00459">110</xref>]. More details on this interaction have been described previously [<xref ref-type="bibr" rid="B111-microorganisms-07-00459">111</xref>]. Several studies reported that co-colonization by <italic>C. albicans</italic> and <italic>P. aeruginosa</italic> occurs at a statistically significant frequency and results in a decrease of pulmonary function, leading to inferior clinical outcome. Although the mortality rates in some <italic>in vivo</italic> models including mouse and zebrafish were elevated, possibly as a result of exacerbated inflammatory response, the differential outcomes in various animal models are still a matter of controversy [<xref ref-type="bibr" rid="B1-microorganisms-07-00459">1</xref>,<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>,<xref ref-type="bibr" rid="B51-microorganisms-07-00459">51</xref>,<xref ref-type="bibr" rid="B52-microorganisms-07-00459">52</xref>,<xref ref-type="bibr" rid="B86-microorganisms-07-00459">86</xref>]. The effects of this interaction may also depend on the specific colonizing strains and the immune status of the host. Thus, more studies are needed to assess the potential importance of this BFI in the clinical setting.</p>
<p><italic>Candida albicans</italic> and <italic>Streptococcus</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): The strong adherence and synergistic interaction between different <italic>Streptococcus</italic> species and <italic>C. albicans</italic> promoting stable formation of biofilms is well documented, and favors survival and enhanced colonization by these microbes, particularly in the oral cavity and the gastrointestinal tract [<xref ref-type="bibr" rid="B112-microorganisms-07-00459">112</xref>,<xref ref-type="bibr" rid="B113-microorganisms-07-00459">113</xref>]. The adhesins Als1, Als3 and Als5 (agglutinin-like sequence) produced by <italic>Candida</italic> are important for aggregation and adhesion to bacterial cells [<xref ref-type="bibr" rid="B114-microorganisms-07-00459">114</xref>,<xref ref-type="bibr" rid="B115-microorganisms-07-00459">115</xref>,<xref ref-type="bibr" rid="B116-microorganisms-07-00459">116</xref>], while the binding of <italic>Streptococci</italic> is mediated by the cell surface polypeptide CshA and the antigen I/II salivary adhesins SspA and SspB [<xref ref-type="bibr" rid="B115-microorganisms-07-00459">115</xref>]. <italic>C. albicans</italic> induces the growth of various <italic>Streptococcus</italic> species, including <italic>S. oralis, S. gordonii, S. sanguinis, S. mutans</italic>, by stimulating the formation of adhesion sites, reducing the oxygen tension, providing growth factors (e.g., polysaccharides) generated by its metabolic activity, and by inducing biofilm formation of <italic>Streptococcus</italic> spp. via farnesol production [<xref ref-type="bibr" rid="B117-microorganisms-07-00459">117</xref>,<xref ref-type="bibr" rid="B118-microorganisms-07-00459">118</xref>,<xref ref-type="bibr" rid="B119-microorganisms-07-00459">119</xref>]. Importantly, mixed biofilms of <italic>C. albicans</italic> and <italic>Streptococcus</italic> display increased resistance to antifungal and antibiotic treatments [<xref ref-type="bibr" rid="B120-microorganisms-07-00459">120</xref>]. Conversely, <italic>Streptococcus</italic> spp. can promote growth of <italic>C. albicans</italic> by producing lactate, which can be exploited as a carbon source by the fungus [<xref ref-type="bibr" rid="B117-microorganisms-07-00459">117</xref>,<xref ref-type="bibr" rid="B121-microorganisms-07-00459">121</xref>]. Moreover, <italic>Streptococcus</italic> species promote adhesion of <italic>C. albicans</italic> by expressing polysaccharide receptors and polypeptide adhesins. Additionally, <italic>Streptococci</italic> can stimulate hyphal development via secretion of the quorum sensing molecule AI-2 (autoinducing peptide) and by repression of the <italic>C. albicans</italic>-derived quorum sensing molecule farnesol, which functions by suppressing hyphal formation at high cell density [<xref ref-type="bibr" rid="B122-microorganisms-07-00459">122</xref>]. Interestingly, a recent study has shown that isolates of <italic>C. albicans</italic> from patients with recurrent vulvovaginal candidiasis show attenuated hyphal formation in the presence of <italic>S. agalactiae</italic> [<xref ref-type="bibr" rid="B123-microorganisms-07-00459">123</xref>]. Finally, <italic>Streptococcus</italic> species including, specifically, <italic>S. oralis</italic> can also promote dissemination of <italic>C. albicans</italic> to distal organs by currently unknown mechanisms [<xref ref-type="bibr" rid="B113-microorganisms-07-00459">113</xref>]. However, depending on the environmental conditions, <italic>Streptococci</italic> can also inhibit hyphal formation through a diffusible signal factor (DSF) and the competence-stimulating peptide (CSP). The factor DSF, a <italic>trans</italic>-2-decenoic acid, is an intermediate product of unsaturated fatty acid synthesis. This molecule is related to farnesoic acid and farnesol, which are quorum-sensing molecules of <italic>C. albicans</italic> inhibiting filamentation. However, the mechanism of DSF secretion remains unclear. The molecule CSP is only produced during the early exponential phase of growth, and has been shown to increase biofilm formation, acid tolerance, and production of bacteriocin, a peptide toxin [<xref ref-type="bibr" rid="B124-microorganisms-07-00459">124</xref>,<xref ref-type="bibr" rid="B125-microorganisms-07-00459">125</xref>,<xref ref-type="bibr" rid="B126-microorganisms-07-00459">126</xref>]. Despite the potentially differential effects mediated by the interaction of these microorganisms, the net result is most commonly mutual promotion with strong biofilm formation, suggesting that higher dosages of antimicrobial drugs may be required to control or eradicate the infection.</p>
<p><italic>Candida albicans, Candida glabrata</italic>, and <italic>Staphylococcus</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): These microorganisms are responsible for a considerable proportion of hospital infections, and are often co-isolated from urinary tract catheters and in a variety of conditions, including buccal mucositis, cystic fibrosis, keratitis, pneumonia, and wound infections [<xref ref-type="bibr" rid="B127-microorganisms-07-00459">127</xref>,<xref ref-type="bibr" rid="B128-microorganisms-07-00459">128</xref>,<xref ref-type="bibr" rid="B129-microorganisms-07-00459">129</xref>]. The pathogen <italic>Staphylococcus aureus</italic> is reportedly the third most common bacterial species co-isolated with <italic>C. albicans</italic> [<xref ref-type="bibr" rid="B130-microorganisms-07-00459">130</xref>]. Adhesion of <italic>S. aureus</italic> to <italic>C. albicans</italic> creates a more extensive biofilm, particularly when this bacterium binds to the hyphal form, which displays 30-fold higher adhesion rates compared to the yeast form [<xref ref-type="bibr" rid="B84-microorganisms-07-00459">84</xref>]. Biofilm formation in catheters in <italic>in vivo</italic> models of <italic>S. aureus</italic> infections is enhanced by the presence of <italic>C. albicans</italic> through the attachment of Als3 to <italic>S. aureus</italic> adhesins [<xref ref-type="bibr" rid="B84-microorganisms-07-00459">84</xref>,<xref ref-type="bibr" rid="B131-microorganisms-07-00459">131</xref>]. Prostaglandin (PG) E2 produced by <italic>C. albicans</italic> is involved in stimulating growth and biofilm formation of <italic>S. aureus</italic> in co-culture, and fungal cell wall polysaccharides secreted into the biofilm matrix increase the tolerance of <italic>S. aureus</italic> to antimicrobial treatment [<xref ref-type="bibr" rid="B127-microorganisms-07-00459">127</xref>,<xref ref-type="bibr" rid="B132-microorganisms-07-00459">132</xref>]. Moreover, <italic>C. albicans</italic> was shown to promote systemic dissemination of <italic>S. aureus</italic> to the kidneys in a murine model of oral co-colonization [<xref ref-type="bibr" rid="B131-microorganisms-07-00459">131</xref>]. Conversely, <italic>S. aureus</italic> supports adhesion of <italic>C. albicans</italic> to the buccal mucosa via the production of proteinase [<xref ref-type="bibr" rid="B133-microorganisms-07-00459">133</xref>]. However, in the presence of farnesol, either externally added into culture or secreted by <italic>C. albicans,</italic> the viability and capacity of biofilm formation of <italic>S. aureus</italic> were reduced, owing to the ability of farnesol to disrupt the cell membrane integrity of the bacterial pathogen [<xref ref-type="bibr" rid="B134-microorganisms-07-00459">134</xref>]. This resulted in increased susceptibility to antibiotic treatment and impaired growth [<xref ref-type="bibr" rid="B135-microorganisms-07-00459">135</xref>,<xref ref-type="bibr" rid="B136-microorganisms-07-00459">136</xref>]. Another <italic>Staphylococcus</italic> species, <italic>S. epidermidis</italic>, adheres to both yeast and hyphal forms of <italic>C. albicans,</italic> and the extracellular matrix produced by <italic>S. epidermidis</italic> protects the fungus [<xref ref-type="bibr" rid="B100-microorganisms-07-00459">100</xref>]. This association also results in increased resistance to antimicrobial drugs including, for example, fluconazole and vancomycin [<xref ref-type="bibr" rid="B100-microorganisms-07-00459">100</xref>]. In contrast to the largely synergistic interactions outlined above, an antagonistic relationship of <italic>S. aureus</italic> towards <italic>C. glabrata</italic> conveyed by an apoptosis-mediated mechanism has recently been described. However, the molecular mediators of this effect have not been identified to date [<xref ref-type="bibr" rid="B137-microorganisms-07-00459">137</xref>].</p>
<p><italic>Candida albicans</italic> and <italic>Enterococcus faecalis</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): These microorganisms can be commonly isolated from a variety of clinical samples [<xref ref-type="bibr" rid="B138-microorganisms-07-00459">138</xref>,<xref ref-type="bibr" rid="B139-microorganisms-07-00459">139</xref>], and the bacterium secretes a compound that inhibits hyphal formation of <italic>C. albicans</italic> via the Fsr quorum sensing system. Two proteases expressed by Fsr, GelE (gelatinase, a metalloprotease II) and SerE (serine protease), play an important role in this process [<xref ref-type="bibr" rid="B140-microorganisms-07-00459">140</xref>]. This inhibitory effect was also observed in an <italic>in vivo</italic> model using <italic>Caenorhabditis elegans</italic> as a host organism for the co-infection, where filamentation of <italic>C. albicans</italic> was inhibited, yet the worm was killed by the infection [<xref ref-type="bibr" rid="B138-microorganisms-07-00459">138</xref>]. The bacteriocin EntV secreted by <italic>E. faecalis</italic> has been recently identified as the compound inhibiting the yeast-to-hyphae transition of <italic>C. albicans</italic>, resulting in decreased virulence and biofilm formation [<xref ref-type="bibr" rid="B140-microorganisms-07-00459">140</xref>,<xref ref-type="bibr" rid="B141-microorganisms-07-00459">141</xref>]. This small peptide was also able to degrade mature fungal biofilms and reduce the virulence of <italic>C. albicans</italic> in a mouse model [<xref ref-type="bibr" rid="B141-microorganisms-07-00459">141</xref>]. In another study, <italic>E. faecalis</italic> was found to produce a non-hemolytic anti-<italic>Candida</italic> protein [<xref ref-type="bibr" rid="B142-microorganisms-07-00459">142</xref>]. Adhesion of <italic>C. albicans</italic> to <italic>E. faecalis</italic> (and other bacteria, such as <italic>Streptococci</italic>), is mediated by the cell wall-associated, secreted aspartyl proteinase Sap9, playing an important role in biofilm development [<xref ref-type="bibr" rid="B143-microorganisms-07-00459">143</xref>]. This suggests that factors produced by <italic>E. faecalis</italic> could be exploited as adjuvants for treatment of <italic>Candida</italic> infection. Additionally, inhibitors of adhesion and biofilm formation may also attenuate virulence and prevent invasive infection by <italic>Candida</italic>.</p>
<p><italic>Candida albicans</italic> and <italic>Lactobacillus</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): The bacterium displays inhibitory effects against <italic>C. albicans.</italic> This interaction is relevant in the female reproductive tract, which is populated by <italic>Lactobacilli</italic> under physiological conditions. The bacteria counteract colonization by <italic>C. albicans</italic> by reducing adhesion of the fungus to epithelial cells. This is achieved via outcompeting the fungal cells for adhesion sites or by decreasing fungal binding through surlactin, a biosurfactant secreted by the bacteria [<xref ref-type="bibr" rid="B8-microorganisms-07-00459">8</xref>,<xref ref-type="bibr" rid="B144-microorganisms-07-00459">144</xref>]. <italic>Lactobacillus</italic> species are able to inhibit hyphal formation of <italic>C. albicans</italic> through soluble metabolic products, short-chain fatty acids (SCFA), H<sub>2</sub>O<sub>2</sub>, and lactic acid. Under glucose-limiting conditions, which occur as a result of carbon deprivation during alkalinization, similar to the conditions existing in phagocytic cells, <italic>C. albicans</italic> can raise the environmental pH by excreting ammonia, thereby inducing hyphal formation [<xref ref-type="bibr" rid="B145-microorganisms-07-00459">145</xref>,<xref ref-type="bibr" rid="B146-microorganisms-07-00459">146</xref>,<xref ref-type="bibr" rid="B147-microorganisms-07-00459">147</xref>].</p>
<p><italic>Candida albicans</italic> and <italic>Escherichia coli</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): Murine models have shown that co-infection with <italic>C. albicans</italic> and <italic>E. coli</italic> resulted in synergistic lethality. In this case, endotoxins produced by <italic>E. coli</italic> during the interaction were identified as the key virulence factors contributing to the high mortality [<xref ref-type="bibr" rid="B59-microorganisms-07-00459">59</xref>,<xref ref-type="bibr" rid="B60-microorganisms-07-00459">60</xref>]. In contrast to the observations in murine models, Hall and colleagues reported that, in the human host, the fungus can apparently suppress the growth of <italic>E. coli</italic>, either directly or indirectly, by dominant interaction during colonization. Under physiological conditions, this effect could possibly inhibit migration of <italic>E. coli</italic> from the rectum to the vaginal area, thereby offering protection against urinary tract infections caused by <italic>E. coli</italic> and other bacteria [<xref ref-type="bibr" rid="B58-microorganisms-07-00459">58</xref>]. However, more studies are required to assess the net effects of this interaction in the clinical setting.</p>
<p><italic>Candida albicans</italic> and <italic>Actinomyces</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): The fungus is able to adhere to different species of <italic>Actinomyces,</italic> which are part of the oral bacterial flora, but <italic>in vitro</italic> studies have shown that the level of aggregation is dependent on the <italic>C. albicans</italic> strain and the culture medium [<xref ref-type="bibr" rid="B148-microorganisms-07-00459">148</xref>,<xref ref-type="bibr" rid="B149-microorganisms-07-00459">149</xref>,<xref ref-type="bibr" rid="B150-microorganisms-07-00459">150</xref>]. This interaction is mediated by a protein on the <italic>Candida</italic> surface that interacts with carbohydrate molecules on the surface of <italic>Actinomyces.</italic> This association results in enhanced cariogenic virulence promoted by increased adhesion, increased biofilm formation, and decreased pH, contributing to oral colonization and oral candidiasis [<xref ref-type="bibr" rid="B149-microorganisms-07-00459">149</xref>,<xref ref-type="bibr" rid="B151-microorganisms-07-00459">151</xref>].</p>
<p><italic>Candida albicans</italic> and <italic>Acinetobacter baumannii</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): Association of these microorganisms has been found in clinical isolates from intensive care units [<xref ref-type="bibr" rid="B152-microorganisms-07-00459">152</xref>], and their interaction displays mutually inhibitory effects. While <italic>A. baumannii</italic> affects hyphal growth of <italic>C. albicans</italic> and can induce apoptotic cell death via contact-dependent signals mediated by the outer-membrane protein A (OmpA) [<xref ref-type="bibr" rid="B153-microorganisms-07-00459">153</xref>,<xref ref-type="bibr" rid="B154-microorganisms-07-00459">154</xref>], <italic>C. albicans</italic> responds to the inhibition of filamentation by suppressing the growth of <italic>A. baumannii</italic> [<xref ref-type="bibr" rid="B153-microorganisms-07-00459">153</xref>]. This effect is conveyed by the secretion of farnesol, which inhibits biofilm formation and reduces the viability of <italic>A. baumannii</italic> [<xref ref-type="bibr" rid="B152-microorganisms-07-00459">152</xref>,<xref ref-type="bibr" rid="B155-microorganisms-07-00459">155</xref>]. The actual clinical impact is difficult to assess, as clinical studies from different intensive care units (ICUs) have indicated a considerable variation in the rate of invasive infections [<xref ref-type="bibr" rid="B156-microorganisms-07-00459">156</xref>].</p>
<p><italic>Candida albicans</italic> and <italic>Aggregatibacter actinomycetemcomitans</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): The bacterium is a Gram-negative opportunistic pathogen causing oral diseases. It produces the quorum-sensing molecule autoinducer-2 (AI-2), inhibiting hyphal structures and biofilm formation of <italic>C. albicans in vitro</italic> [<xref ref-type="bibr" rid="B157-microorganisms-07-00459">157</xref>]. However, the inhibitory interaction observed <italic>in vitro</italic> was not confirmed in the clinical setting. Concomitant isolation of these two microorganisms in women using oral contraceptives has been associated with moderate to severe periodontitis, rather supporting a synergistic effect of the interaction [<xref ref-type="bibr" rid="B158-microorganisms-07-00459">158</xref>]. Despite the questionable association of <italic>Candida</italic> infection with periodontitis, the presence of saliva, which is a strong inducer of hyphal formation, might be responsible for a synergistic effect of the co-infection [<xref ref-type="bibr" rid="B157-microorganisms-07-00459">157</xref>,<xref ref-type="bibr" rid="B159-microorganisms-07-00459">159</xref>]. However, the net effect of this interaction may depend on the amount of bacterial AI-2 produced in saliva-fed biofilms.</p>
<p><italic>Candida albicans</italic> and <italic>Serratia marcescens</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): Although the mechanism of interaction has not been identified to date, <italic>C. albicans</italic> apparently displays a stimulatory effect on the Gram-negative bacterium, enhancing its virulence. This effect has been documented in the peritoneal cavity, and was shown to promote dissemination of the bacterium to several abdominal organs. A similar stimulatory effect was also documented for other bacterial species, including <italic>S. aureus</italic> and <italic>S. faecalis</italic> [<xref ref-type="bibr" rid="B100-microorganisms-07-00459">100</xref>,<xref ref-type="bibr" rid="B160-microorganisms-07-00459">160</xref>]. This is of particular importance in immunocompromised patients, in whom disseminated infection may result in severe sepsis.</p>
<p><italic>Candida albicans, Candida dubliniensis,</italic> and <italic>Fusobacterium</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): The indicated fungi adhere well to several species of <italic>Fusobacterium</italic>, including, for example, <italic>F. nucleatum</italic>, <italic>F. periodontium,</italic> and <italic>F. sulci</italic>, which are colonizers of the oral mucosa [<xref ref-type="bibr" rid="B161-microorganisms-07-00459">161</xref>,<xref ref-type="bibr" rid="B162-microorganisms-07-00459">162</xref>,<xref ref-type="bibr" rid="B163-microorganisms-07-00459">163</xref>]. The aggregation, resulting in mutual inhibition, is thought to be mediated by bacterial lectins, which may interact with carbohydrates on the cell wall surface of <italic>Candida</italic> [<xref ref-type="bibr" rid="B161-microorganisms-07-00459">161</xref>,<xref ref-type="bibr" rid="B162-microorganisms-07-00459">162</xref>]. Recently, additional mediators promoting aggregation of these two microorganisms were identified, involving the bacterial membrane protein RadD, and the <italic>Candida</italic> adhesin-like cell wall mannoprotein Flo9 [<xref ref-type="bibr" rid="B164-microorganisms-07-00459">164</xref>]. Mutual adherence was only observed in the presence of the hyphal form, but not in the yeast form of <italic>C. albicans</italic> [<xref ref-type="bibr" rid="B165-microorganisms-07-00459">165</xref>]. However, the strong co-aggregation could be inhibited by externally added arginine and mannose, which disrupt the proteins RadD and Flo9, respectively [<xref ref-type="bibr" rid="B165-microorganisms-07-00459">165</xref>]. The level of co-aggregation and the inhibitory effects were shown to be strain-dependent [<xref ref-type="bibr" rid="B163-microorganisms-07-00459">163</xref>]. Moreover, the effect of the bacterial–fungal interaction <italic>in vitro</italic> may also be influenced by the growth conditions. Recently, the proteins RadD and Flo9 were found to be involved in the inhibition of hyphal formation of <italic>C. albicans</italic> under specific growth conditions [<xref ref-type="bibr" rid="B164-microorganisms-07-00459">164</xref>]. Growth and filamentation of <italic>C. albicans</italic> were found to be inhibited by <italic>F. nucleatum</italic> in a contact-dependent process [<xref ref-type="bibr" rid="B164-microorganisms-07-00459">164</xref>,<xref ref-type="bibr" rid="B165-microorganisms-07-00459">165</xref>]. These studies suggest that the association between <italic>Candida</italic> and <italic>Fusobacterium</italic> may permit a long-term commensal state in the oral mucosa [<xref ref-type="bibr" rid="B164-microorganisms-07-00459">164</xref>]. However, more studies are needed to assess the impact of this bacterial–fungal interaction in the host, including studies in <italic>in vivo</italic> models.</p>
<p><italic>Candida albicans</italic> and <italic>Burkholderia</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): The bacterium <italic>B. cenocepacia</italic> is an opportunistic pathogen found in the respiratory tract. It is mostly acquired from the environment, via hospital devices or by person-to-person spread, and is only rarely carried as a commensal microorganism [<xref ref-type="bibr" rid="B166-microorganisms-07-00459">166</xref>,<xref ref-type="bibr" rid="B167-microorganisms-07-00459">167</xref>]. <italic>B. cenocepacia</italic> produces a quorum-sensing molecule termed <italic>cis</italic>-2-dodecenoic acid (BDSF), which inhibits initiation of hyphal formation in <italic>C. albicans</italic> [<xref ref-type="bibr" rid="B168-microorganisms-07-00459">168</xref>]. This molecule can also inhibit adherence of <italic>C. albicans</italic> to urinary catheters, as revealed by <italic>in vitro</italic> models [<xref ref-type="bibr" rid="B169-microorganisms-07-00459">169</xref>].</p>
<p><italic>Candida albicans</italic> and <italic>Clostridium</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): These Gram-positive bacteria are obligate anaerobes, and the growth of certain species is promoted by <italic>C. albicans</italic> under hypoxic conditions [<xref ref-type="bibr" rid="B170-microorganisms-07-00459">170</xref>]. However, the presence of <italic>C. albicans</italic> can also be exploited by <italic>Clostridium difficile</italic> to facilitate its growth under aerobic conditions [<xref ref-type="bibr" rid="B171-microorganisms-07-00459">171</xref>]. It has been suggested that <italic>C. albicans</italic> may use its metabolism to reduce the oxygen tension or produce antioxidants such as tyrosol, which would favor the growth of anaerobic bacteria [<xref ref-type="bibr" rid="B172-microorganisms-07-00459">172</xref>,<xref ref-type="bibr" rid="B173-microorganisms-07-00459">173</xref>]. This indicates that <italic>C. albicans</italic> may promote the growth of strictly anaerobic bacteria within oxygen-rich environments [<xref ref-type="bibr" rid="B174-microorganisms-07-00459">174</xref>]. Conversely, <italic>C. difficile</italic> produces <italic>p</italic>-Cresol, a fermentation product derived from tyrosine, displaying inhibitory effects on hyphal formation of <italic>C. albicans</italic>. The compound induces hypha-to-yeast transition, and inhibits biofilm formation and virulence of <italic>C. albicans</italic> [<xref ref-type="bibr" rid="B171-microorganisms-07-00459">171</xref>]. These observations raise the possibility that treatment approaches affecting the aerobic vs. anaerobic environmental conditions may favor the growth of a certain pathogen. Moreover, these studies suggest that patients harboring a <italic>C. difficile</italic> infection might be less prone to developing a systemic <italic>Candida</italic> infection. Conversely, however, elimination of the bacterium by appropriate treatment could promote expansion of the fungus.</p>
<p><italic>Candida albicans</italic> and <italic>Bacteroides fragilis</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): Current knowledge on the interaction between these microorganisms is restricted to the observation that growth of the Gram-negative bacterium <italic>B. fragilis</italic> is promoted by <italic>C. albicans</italic> under aerobic conditions [<xref ref-type="bibr" rid="B170-microorganisms-07-00459">170</xref>].</p>
<p><italic>Candida albicans</italic> and <italic>Salmonella enterica</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): The serovar <italic>typhimurium</italic> of <italic>S. enterica</italic> has been described as inhibiting growth, hyphal formation, and viability of <italic>C. albicans</italic>. It has been suggested that a quorum-sensing molecule secreted by the bacterium might be responsible for this effect [<xref ref-type="bibr" rid="B175-microorganisms-07-00459">175</xref>], and recent data indicate that it is apparently mediated by inositol phosphatase (sopB), an effector of the type III secretion system [<xref ref-type="bibr" rid="B176-microorganisms-07-00459">176</xref>].</p>
<p><italic>Candida albicans</italic> and <italic>Klebsiella pneumoniae</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f001">Figure 1</xref>): Antagonistic interactions between the Gram-negative bacterium <italic>K. pneumoniae</italic> and <italic>C. albicans</italic> have been reported. The bacterium adheres to both yeast and hyphal structures of <italic>C. albicans</italic>, and inhibits growth of the fungus. However, the specific mechanisms of this interaction have not yet been elucidated [<xref ref-type="bibr" rid="B170-microorganisms-07-00459">170</xref>].</p>
</sec>
<sec id="sec3dot1dot2-microorganisms-07-00459">
<title>3.1.2. <italic>Aspergillus</italic> Species and Bacteria </title>
<p><italic>Aspergillus fumigatus</italic> and <italic>Pseudomonas aeruginosa</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f002">Figure 2</xref>): Co-localization of <italic>A. fumigatus</italic> and <italic>P. aeruginosa</italic> in the lungs of patients with cystic fibrosis has been associated with poorer outcomes when compared to single infections with these pathogens [<xref ref-type="bibr" rid="B53-microorganisms-07-00459">53</xref>,<xref ref-type="bibr" rid="B85-microorganisms-07-00459">85</xref>]. <italic>P. aeruginosa</italic> has the capacity to inhibit the growth of <italic>A. fumigatus</italic> [<xref ref-type="bibr" rid="B177-microorganisms-07-00459">177</xref>,<xref ref-type="bibr" rid="B178-microorganisms-07-00459">178</xref>,<xref ref-type="bibr" rid="B179-microorganisms-07-00459">179</xref>,<xref ref-type="bibr" rid="B180-microorganisms-07-00459">180</xref>]. This interaction occurs through the production of quorum-sensing molecules and virulence factors by <italic>P. aeruginosa,</italic> including, for example, phenazines, decanol, and 3-oxo-C12-homoserine lactone (3OC<sub>12</sub>HSL), which affect hyphal development through the generation of highly toxic reactive oxygen species (ROS) [<xref ref-type="bibr" rid="B179-microorganisms-07-00459">179</xref>,<xref ref-type="bibr" rid="B181-microorganisms-07-00459">181</xref>,<xref ref-type="bibr" rid="B182-microorganisms-07-00459">182</xref>]. Moreover, the inhibitory effect also involves the phenazine derivatives, pyrrolnitrin and pyocyanin [<xref ref-type="bibr" rid="B182-microorganisms-07-00459">182</xref>], and the LasIR quorum sensing system has been implicated in inhibiting <italic>A. fumigatus</italic> biofilms [<xref ref-type="bibr" rid="B181-microorganisms-07-00459">181</xref>]. Conversely, <italic>A. fumigatus</italic> was recently found to be able to inhibit <italic>P. aeruginosa</italic> in mixed culture, leading to reduced biofilm formation. The compound gliotoxin produced by <italic>A. fumigatus</italic> was identified as the main agent responsible for the inhibitory effect. In addition, iron regulation also plays a key role in this interaction. <italic>A. fumigatus</italic> produces siderophores that help the fungus protect itself against iron-chelation by <italic>P. aeruginosa</italic> [<xref ref-type="bibr" rid="B183-microorganisms-07-00459">183</xref>]. The indicated interactions are mutually antagonistic [<xref ref-type="bibr" rid="B180-microorganisms-07-00459">180</xref>], thus failing to provide a rational explanation for the clinical impact of the co-infection, but <italic>P. aeruginosa</italic> also has the capability to produce volatile compounds that stimulate the growth of <italic>A. fumigatus</italic> at a distance rather than by direct contact [<xref ref-type="bibr" rid="B184-microorganisms-07-00459">184</xref>].</p>
<p><italic>Aspergillus nidulans</italic> and <italic>Streptomyces rapamycinicus</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f002">Figure 2</xref>): The Gram-positive bacteria of the genus <italic>Streptomyces</italic> are normally encountered in soil. Although infections in humans are rare, <italic>Streptomyces</italic> can activate genes of secondary fungal metabolism, including those responsible for synthesis of antibiotic and aromatic polyketides [<xref ref-type="bibr" rid="B185-microorganisms-07-00459">185</xref>]. The activation requires physical contact between <italic>A. nidulans</italic> and <italic>S. rapamycinicus</italic> [<xref ref-type="bibr" rid="B186-microorganisms-07-00459">186</xref>]. This interaction is thought to reflect a symbiotic relationship, with activation of silent gene clusters in the fungus mediated by chromatin remodelling [<xref ref-type="bibr" rid="B185-microorganisms-07-00459">185</xref>]. Recent findings suggest a new transcription factor, BasR, as a key regulator for the transduction of the bacterial signal [<xref ref-type="bibr" rid="B187-microorganisms-07-00459">187</xref>]. The findings suggest that infections with <italic>Streptomyces</italic> may change the local environment and alter the microbial composition by activating fungal-derived synthesis of antibiotic compounds.</p>
<p><italic>Aspergillus niger</italic> and <italic>Salmonella</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f002">Figure 2</xref>): The interaction between <italic>A. niger</italic> and <italic>Salmonella</italic> spp., including all serovars of <italic>S. enterica</italic>, is mediated by attachment of the bacterial cellulose to the fungal cell wall component chitin on hyphae of <italic>A. niger</italic>, promoting the formation of multi-layered and branched biofilms [<xref ref-type="bibr" rid="B188-microorganisms-07-00459">188</xref>]. Although the potential clinical consequences of this interaction have not been elucidated, it is conceivable that the enhanced capacity to bind fungi via cellulose production may result in stronger biofilm formation, thus contributing to increased antimicrobial resistance. Cellulose production by pathogenic bacteria may therefore constitute a survival advantage.</p>
<p><italic>Aspergillus</italic> spp. and <italic>Klebsiella pneumoniae</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f002">Figure 2</xref>): Recently, studies performed in our laboratory have shown that <italic>K. pneumoniae</italic> exerts an inhibitory effect on <italic>Aspergillus</italic> species, including <italic>A. fumigatus, A. terreus, A. niger,</italic> and <italic>A. flavus</italic>. <italic>Aspergillus</italic> spore germination was inhibited, as well as the development of pre-formed hyphal structures. <italic>K. pneumoniae</italic> also significantly decreased biofilm formation of <italic>Aspergillus</italic> species [<xref ref-type="bibr" rid="B189-microorganisms-07-00459">189</xref>]. The exact mechanisms and molecules involved in this interaction are currently under investigation. The clinical impact of this bacterial–fungal interaction may be of particular importance in the setting of cystic fibrosis and other lung-associated diseases because both pathogens co-habit in the lungs.</p>
</sec>
<sec id="sec3dot1dot3-microorganisms-07-00459">
<title>3.1.3. Cryptococcus Species and Bacteria </title>
<p><italic>Cryptococcus</italic> spp. and <italic>Pseudomonas aeruginosa</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f003">Figure 3</xref>): The lungs of immunocompromised patients commonly display the concomitant presence of <italic>Cryptococcus</italic> spp., including in particular <italic>C. neoformans</italic>, and <italic>P. aeruginosa,</italic> and the bacterium has the capacity to inhibit the growth of <italic>Cryptococcus</italic> spp. [<xref ref-type="bibr" rid="B190-microorganisms-07-00459">190</xref>,<xref ref-type="bibr" rid="B191-microorganisms-07-00459">191</xref>]. The inhibitory effect occurs mainly through the production of the metabolite pyocyanin, but also by the production of alkylquinolones such as HHQ (4-hydroxy-2-heptylquinoline) and PQS (3,4-dihydroxy-2-heptylquinoline) [<xref ref-type="bibr" rid="B105-microorganisms-07-00459">105</xref>,<xref ref-type="bibr" rid="B106-microorganisms-07-00459">106</xref>,<xref ref-type="bibr" rid="B190-microorganisms-07-00459">190</xref>,<xref ref-type="bibr" rid="B191-microorganisms-07-00459">191</xref>]. Cell contact is necessary for maximum inhibition of <italic>Cryptococcus</italic> growth [<xref ref-type="bibr" rid="B190-microorganisms-07-00459">190</xref>]. The clinical impact of this interaction is currently unknown.</p>
<p><italic>Cryptococcus neoformans</italic> and <italic>Klebsiella aerogenes</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f003">Figure 3</xref>): This bacterial species induces melanin production by <italic>C. neoformans</italic> through secretion of dopamine by the bacterium, thereby leading to enhanced protection of <italic>C. neoformans</italic> from macrophages [<xref ref-type="bibr" rid="B192-microorganisms-07-00459">192</xref>,<xref ref-type="bibr" rid="B193-microorganisms-07-00459">193</xref>]. Enhanced melanization of <italic>Cryptococcus</italic> may also confer a protective effect against antifungal treatment.</p>
</sec>
<sec id="sec3dot1dot4-microorganisms-07-00459">
<title>3.1.4. Interaction of Other Fungal Species with Bacteria </title>
<p><italic>Cladosporium</italic> spp. and <italic>Bacillus subtilis</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f003">Figure 3</xref>): Different species of the mould <italic>Cladosporium</italic> are involved in mediating allergic reactions, particularly in individuals with pre-existent respiratory diseases, and can also cause infections of the skin, sinuses, and lungs [<xref ref-type="bibr" rid="B194-microorganisms-07-00459">194</xref>]. A class of diphenyl ethers with polyhydroxy sidechains has been identified when <italic>Cladosporium</italic> species and <italic>B. subtilis</italic> interacted <italic>in vitro</italic>, and it was suggested that the production of these compounds may be a defensive response of the fungus against growth inhibition mediated by <italic>B. subtilis</italic> through the secretion of surfactins (antifungal cyclopeptides). Surfactins have been suggested to cause the induction of secondary metabolism in <italic>Cladosporium</italic> spp. [<xref ref-type="bibr" rid="B195-microorganisms-07-00459">195</xref>]. Activation of secondary metabolism and production of specific metabolites may result in increased fitness and virulence of these fungal species in the host.</p>
<p><italic>Rhizopus microsporus</italic> and <italic>Burkholderia</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f003">Figure 3</xref>): Fungi belonging to the genus <italic>Rhizopus</italic> cause infections known as zygomycosis. The fungus <italic>R. microsporus</italic> and the bacterium <italic>Burkholderia gladioli</italic> are plant pathogens but can also cause opportunistic infections in humans [<xref ref-type="bibr" rid="B196-microorganisms-07-00459">196</xref>]. Upon interaction with <italic>R. microsporus</italic>, <italic>B. gladioli</italic> produces the compound bongkrekic acid, which acts as a respiratory toxin, but also results in fungal growth inhibition [<xref ref-type="bibr" rid="B197-microorganisms-07-00459">197</xref>,<xref ref-type="bibr" rid="B198-microorganisms-07-00459">198</xref>]. <italic>R. microsporus</italic> indirectly contributes to production of bongkrekic acid by stimulating bacterial growth [<xref ref-type="bibr" rid="B197-microorganisms-07-00459">197</xref>]. <italic>R. microsporus</italic> can also establish a symbiotic interaction with <italic>B. rhizoxinica.</italic> This endosymbiotic bacterium produces an important compound, rhizoxin, which is essential for fungal spore formation, and is also considered as a mediator of antitumor activity [<xref ref-type="bibr" rid="B199-microorganisms-07-00459">199</xref>]. It is crucial, therefore to assess which pathogens can cause infections in humans and, in the presence of polymicrobial interactions, to identify factors capable of affecting concomitant treatment approaches.</p>
<p><italic>Saccharomyces cerevisiae</italic> and <italic>Acinetobacter</italic> spp. (<xref ref-type="fig" rid="microorganisms-07-00459-f003">Figure 3</xref>): The fungus produces ethanol, which can promote growth of several <italic>Acinetobacter</italic> species, including <italic>A. baumannii, A. haemolyticus, A. johnsonii</italic>, and <italic>A. radioresistens in vitro</italic> [<xref ref-type="bibr" rid="B200-microorganisms-07-00459">200</xref>]. As demonstrated for <italic>A. baumannii</italic> in a <italic>C. elegans in vivo</italic> model, these BFI can result in increased bacterial resistance to osmotic stress associated with enhanced pathogenicity and virulence [<xref ref-type="bibr" rid="B200-microorganisms-07-00459">200</xref>]. Improved fitness of these bacteria might be of particular interest in patients with high alcohol consumption [<xref ref-type="bibr" rid="B201-microorganisms-07-00459">201</xref>], and could ultimately affect the responsiveness to antimicrobial treatment. </p>
<p><italic>Scedosporium aurantiacum</italic> and <italic>Pseudomonas aeruginosa</italic> (<xref ref-type="fig" rid="microorganisms-07-00459-f003">Figure 3</xref>): The filamentous fungus <italic>S. aurantiacum</italic> is an opportunistic pathogen that can be isolated from the lungs of patients with cystic fibrosis. Interactions between this fungus and <italic>P. aeruginosa,</italic> one of the most important bacteria in this disease, were shown to be inhibitory for the fungus. The effect does not require biofilm formation involving <italic>P. aeruginosa,</italic> but metabolites secreted by the bacterium are suspected to be responsible for the inhibitory interaction. Pyocyanin, a molecule commonly secreted by <italic>P. aeruginosa,</italic> showed no effect against the fungus [<xref ref-type="bibr" rid="B202-microorganisms-07-00459">202</xref>,<xref ref-type="bibr" rid="B203-microorganisms-07-00459">203</xref>] and the mediators of inhibition, and thus the potential clinical impact of the interaction remains obscure.</p>
</sec>
</sec>
</sec>
<sec id="sec4-microorganisms-07-00459">
<title>4. Host Immune Response to Bacterial and Fungal (Co-)Infections</title>
<p>Perturbations of the microbiome and weakening of the host immune system are conditions facilitating the transition of opportunistic microbes from a commensal to a pathogenic state, mediating the initiation of infection. Microbiota can also influence gene expression of mucins and toll-like receptors (TLRs) by the host, and mediate modulation of the immune system and apoptosis [<xref ref-type="bibr" rid="B32-microorganisms-07-00459">32</xref>]. Factors predisposing the human host for invasive fungal infections include i) long-term or repeated exposure to broad-spectrum antibiotics; ii) impairment of epithelial barriers affecting the skin, the gastrointestinal tract, or other mucous membranes, e.g., by chemotherapy, surgery or central venous catheters; and iii) treatment with immunosuppressive agents such as corticosteroids [<xref ref-type="bibr" rid="B204-microorganisms-07-00459">204</xref>].</p>
<p>The interaction between microbial pathogens and the host induces the activation of several virulence factors and adaptation mechanisms [<xref ref-type="bibr" rid="B204-microorganisms-07-00459">204</xref>]. In fungal infections, the virulence factors include morphological transitions (e.g. yeast-to-hyphae), phenotypic switching (e.g., white to opaque state in <italic>C. albicans</italic>), biofilm formation, increased adhesion capacity, and environmental pH modulation [<xref ref-type="bibr" rid="B205-microorganisms-07-00459">205</xref>].</p>
<p>The first line of defense against fungal pathogens is mediated by the innate immune response. Pattern recognition receptors (PRRs) expressed on the surface of immune cells recognize pathogen-associated molecular patterns (PAMPs) which comprise several cell wall components, such as mannans, mannoproteins, β-glucans, and chitin, as well as fungal-derived RNA and unmethylated DNA [<xref ref-type="bibr" rid="B206-microorganisms-07-00459">206</xref>]. PRRs include toll-like receptors (TLRs) and C-type lectin receptors (CLRs), which are present on macrophages and dendritic cells. Upon ligand binding, the immune response is initiated through a series of signaling cascades, which, in turn, result in fungal internalization via phagocytosis, and production of cytokines and reactive nitrogen and oxygen species (RNS and ROS) [<xref ref-type="bibr" rid="B206-microorganisms-07-00459">206</xref>]. Most of the fungal cell wall components can be recognized by TLR2, TLR4, and TLR9, which trigger the activation of dendritic cells and transcription of proinflammatory cytokines (IL-1β, IL-6, IL-23) [<xref ref-type="bibr" rid="B207-microorganisms-07-00459">207</xref>,<xref ref-type="bibr" rid="B208-microorganisms-07-00459">208</xref>]. Proinflammatory cytokines bind to receptors on Th17 cells [<xref ref-type="bibr" rid="B208-microorganisms-07-00459">208</xref>]. Neutrophils play a key role against bacterial pathogens by producing large amounts of cytotoxic ROS, proteases, and antimicrobial peptides [<xref ref-type="bibr" rid="B209-microorganisms-07-00459">209</xref>,<xref ref-type="bibr" rid="B210-microorganisms-07-00459">210</xref>], but also play an essential role in the defense against fungal infections. In response to chemotactic factors released by the pathogens and the host, neutrophils rapidly migrate to the infection site, and neutropenia is therefore a risk factor for both fungal and bacterial infections associated with adverse clinical outcome [<xref ref-type="bibr" rid="B204-microorganisms-07-00459">204</xref>,<xref ref-type="bibr" rid="B211-microorganisms-07-00459">211</xref>]. However, excessive accumulation of neutrophils in the course of an infection leads to increased tissue damage, underlining the potential pathogenic effect of the immune response [<xref ref-type="bibr" rid="B204-microorganisms-07-00459">204</xref>]. Synergistic associations between different PRRs (e.g., TLR2 and Dectin-1) have also been found to facilitate the PAMP recognition and to enhance downstream responses [<xref ref-type="bibr" rid="B204-microorganisms-07-00459">204</xref>]. However, the immune response is not always effective. Fungi have developed several mechanisms and strategies to escape the attack of the immune system. The escape mechanisms essentially include shielding of PAMPs through the cell wall or capsule, and the formation of biofilms, titan cells, asteroid bodies, or dimorphism (yeast-to-hyphae transition). For example, virulence factors of <italic>C. albicans</italic> are exclusively expressed at the hyphal stage, and hyphal cells induce low cytokine production compared to yeast cells. Hyphal structures are also important to evade phagocytosis and escape from the immune cells [<xref ref-type="bibr" rid="B211-microorganisms-07-00459">211</xref>].</p>
<p>Bacteria have also developed mechanisms to hide or escape from the immune system. Some of these mechanisms are similar to those used by fungi. Biofilm formation is also an important feature used by bacteria to evade the immune response. Other factors include the secretion of proteins, quorum sensing regulation, production of antigenic exotoxins, pore-forming toxins, and capsular polysaccharides. Different capsular serotypes exist in bacteria and differ in their chemistry and antigenicity [<xref ref-type="bibr" rid="B210-microorganisms-07-00459">210</xref>,<xref ref-type="bibr" rid="B212-microorganisms-07-00459">212</xref>,<xref ref-type="bibr" rid="B213-microorganisms-07-00459">213</xref>]. Capsular polysaccharides minimize or even inhibit the host recognition, either by hiding or modifying the cell surface. Bacteria can also dampen opsonization through the expression of proteins on the cell surface or by their secretion. Recruitment of neutrophils to the infection site can be inhibited, and killing of neutrophils may occur through the secretion of toxins or cytolysins [<xref ref-type="bibr" rid="B210-microorganisms-07-00459">210</xref>]. Moreover, bacterial secretion systems may also be used to inject effector proteins directly into the host cells, including immune cells [<xref ref-type="bibr" rid="B214-microorganisms-07-00459">214</xref>], and bacteria have developed mechanisms to manipulate the inflammatory pathways, induce immune cell death (apoptosis, pyroptosis), and tolerate different pH conditions [<xref ref-type="bibr" rid="B212-microorganisms-07-00459">212</xref>,<xref ref-type="bibr" rid="B215-microorganisms-07-00459">215</xref>]. Escape from the immune system may lead to persistent and chronic infection, bearing the risk of potentially life-threatening reactivation occurring particularly in severely immunocompromised individuals.</p>
</sec>
<sec id="sec5-microorganisms-07-00459">
<title>5. <italic>In Vivo</italic> Models of Bacterial and Fungal (Co)-Infections</title>
<p>Bacterial–fungal interactions can display a diverse spectrum of effects, which may not be identical <italic>in vivo</italic> and <italic>in vitro</italic>. For example, the interactions between <italic>C. albicans</italic> and <italic>P. aeruginosa</italic> observed in <italic>in vitro</italic> models are mostly antagonistic, but the interaction in the human host displays synergistic effects on the virulence, resulting in higher mortality [<xref ref-type="bibr" rid="B1-microorganisms-07-00459">1</xref>,<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>,<xref ref-type="bibr" rid="B216-microorganisms-07-00459">216</xref>]. The differential effect may be explained by the host environment and the increased inflammatory response associated with cytokine profiles that are absent <italic>in vitro</italic> and also differ from single pathogen infections (<xref ref-type="table" rid="microorganisms-07-00459-t001">Table 1</xref>). Co-infection with <italic>C. albicans</italic> and <italic>P. aeruginosa</italic> revealed significant upregulation of the proinflammatory cytokine IL-6 and a less prominent increase of IL-8, a potent chemoattractant of neutrophils in a zebrafish <italic>in vivo</italic> model [<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>]. However, other studies in mice have shown that infection with <italic>C. albicans</italic> mediates a protective effect against lung tissue damage induced by <italic>P. aeruginosa</italic>. This effect reportedly occurs by triggering IL-22 production, activation of the IL-17 pathway, and via stimulating the production of antimicrobial peptides by the host [<xref ref-type="bibr" rid="B99-microorganisms-07-00459">99</xref>]. Similarly, co-infection of <italic>P. aeruginosa</italic> and <italic>A. fumigatus</italic> has also been described as resulting in poorer outcomes in cystic fibrosis patients, in comparison to infections by single-pathogens [<xref ref-type="bibr" rid="B53-microorganisms-07-00459">53</xref>]. In contrast to the observations in the human host, no additive effect on the inflammatory response was observed in corresponding co-culture experiments in the wax moth <italic>Galleria mellonella</italic> model. The lack of synergistic inflammatory response in epithelial cells of cystic fibrosis patients may be explained by the saturation of signaling pathways for cytokine production, since both organisms activate the same pathways [<xref ref-type="bibr" rid="B180-microorganisms-07-00459">180</xref>]. <italic>Streptococcus</italic> species are very important colonizers of the oral mucosa. A co-infection with <italic>C. albicans</italic> is synergistically pathogenic in a murine model, leading to the formation of hypervirulent mucosal biofilms [<xref ref-type="bibr" rid="B113-microorganisms-07-00459">113</xref>,<xref ref-type="bibr" rid="B217-microorganisms-07-00459">217</xref>], and the inflammatory response has been shown to be dependent on TLR-2 signalling, with specific cytokine and genetic signatures associated with this co-infection [<xref ref-type="bibr" rid="B113-microorganisms-07-00459">113</xref>].</p>
<p>Single pathogen infection with <italic>S. aureus</italic> was shown to be avirulent in a mouse model, whereas co-infection with <italic>C. albicans</italic> resulted in 100% mortality within 48–72 h post inoculation [<xref ref-type="bibr" rid="B218-microorganisms-07-00459">218</xref>]. Similar observations were also made in a corresponding co-infection model using <italic>G. mellonella</italic> or <italic>C. elegans</italic>, where enhanced pathogenicity and increased mortality was observed [<xref ref-type="bibr" rid="B219-microorganisms-07-00459">219</xref>,<xref ref-type="bibr" rid="B220-microorganisms-07-00459">220</xref>]. However, the mortality rate in the mouse model was apparently dependent on the <italic>Candida</italic> species involved, as co-infections of <italic>S. aureus</italic> with <italic>C. dubliniensis</italic>, <italic>Candida parapsilosis</italic>, or <italic>C. glabrata</italic> resulted in low or no mortality at all [<xref ref-type="bibr" rid="B218-microorganisms-07-00459">218</xref>]. During these co-infections involving <italic>C. albicans</italic> and <italic>Candida krusei</italic>, IL-6 and prostaglandin E2 (PGE2) were found to be significantly elevated, which was not the case in co-infections with other <italic>Candida</italic> species [<xref ref-type="bibr" rid="B218-microorganisms-07-00459">218</xref>]. </p>
<p>Co-infection of <italic>C. albicans</italic> and <italic>E. coli</italic> also resulted in 100% mortality in a murine model, compared to only 3% and 20% mortality of single infections by <italic>C. albicans</italic> and <italic>E. coli</italic>, respectively [<xref ref-type="bibr" rid="B59-microorganisms-07-00459">59</xref>], and the bacterial endotoxins produced during the co-infection are thought to mediate the synergistic effect on mortality [<xref ref-type="bibr" rid="B59-microorganisms-07-00459">59</xref>].</p>
<p>Surprisingly, in a <italic>C. elegans</italic> model of co-infection with <italic>C. albicans</italic> and <italic>E. faecalis</italic>, the worms lived much longer than upon infection with <italic>C. albicans</italic> only, and this effect was even more dramatic upon sequential exposure to <italic>E. faecalis</italic> followed by <italic>C. albicans</italic>. It is conceivable that priming the host immune system with <italic>E. faecalis</italic> somehow protected the worm against subsequent exposure to <italic>C. albicans</italic>, and the effect is thought to be due to the inhibition of <italic>C. albicans</italic> filamentation, thereby greatly reducing tissue damage in the worm [<xref ref-type="bibr" rid="B138-microorganisms-07-00459">138</xref>,<xref ref-type="bibr" rid="B140-microorganisms-07-00459">140</xref>]. A similar effect was observed in co-infection with <italic>C. albicans</italic> and <italic>A. baumannii</italic> in a <italic>C. elegans</italic> model, where inhibition of <italic>C. albicans</italic> filamentation by <italic>A. baumannii</italic> attenuated the pathogenicity of the fungus, leading to reduced lethality [<xref ref-type="bibr" rid="B153-microorganisms-07-00459">153</xref>].</p>
<p>For many of the bacterial–fungal interactions described above, no data are available regarding the interplay with the host and how the immune system responds to such polymicrobial infections compared to the respective single infections. In <xref ref-type="table" rid="microorganisms-07-00459-t001">Table 1</xref>, important features of the bacterial–fungal interactions and the interplay with the host immune system are summarized. It is important to emphasize again that bacterial–fungal interactions observed <italic>in vitro</italic> can greatly differ from the observations made <italic>in vivo,</italic> either in model animal systems or in the human host. The immune response, including the degree of inflammation, can exert a major effect on factors affecting the pathogenicity and virulence of the individual pathogens involved, and may thus also affect the overall result of the bacterial–fungal interaction.</p>
</sec>
<sec id="sec6-microorganisms-07-00459" sec-type="conclusions">
<title>6. Conclusions</title>
<p>Current data underline the importance of identifying polymicrobial infections involving bacteria and fungi, and taking their possible interactions into consideration as a basis for efficient diagnostics and treatment. Detailed knowledge of clinically relevant bacterial–fungal interactions not yet characterized to date is needed, with particular emphasis on deciphering the ways of communication between multidrug resistant pathogens such as <italic>Candida auris</italic> or methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA). Employment of state-of-the-art technologies, including CRISPR-Cas (clustered regularly interspaced short palindromic repeats) gene editing and mutant libraries, will facilitate the identification of key regulators mediating bacterial–fungal interactions and their interplay with the host immune system. It is necessary to bear in mind, however, that the effects of BFI observed in assays performed <italic>in vitro</italic> can be variable, depending on the experimental conditions, and the results can be discordant with those obtained in different <italic>in vivo</italic> models, thus rendering interpretation of the clinical relevance challenging.</p>
<p>Production of certain metabolites during BFI may result in increased fitness and virulence of the microorganisms involved. As described in this review, bacteria such as <italic>Streptococcus</italic> spp. can promote hyphal development in fungal species. Hyphal structures play a crucial role in the invasion of epithelial cells and organs, thus promoting expansion of the infection. Moreover, hyphae provide better fitness under challenging environmental conditions, mediate increased adhesion properties, and permit strong biofilm development, which is associated with increased antimicrobial resistance. Importantly, dual-species biofilms have shown increased resistance to drug treatment compared to single-species biofilms [<xref ref-type="bibr" rid="B219-microorganisms-07-00459">219</xref>]. Hyphal development, cell adhesion, and biofilm formation often serve as targets for treatment of monoinfections. Since these factors are also affected during many of the bacterial–fungal interactions studied, they may also serve as targets for appropriate treatment strategies in polymicrobial infections. Some authors have argued that specific classes of antifungal drugs, including echinocandins in particular, might prove beneficial for treating or preventing polymicrobial infections by exerting immunomodulatory properties. However, this immune potentiation is apparently non-specific as it also occurs in response to monoinfections [<xref ref-type="bibr" rid="B230-microorganisms-07-00459">230</xref>].</p>
<p>New diagnostic approaches based on the identification and exploitation of novel biomarkers for BFI that will expectedly emanate from ongoing research are required for appropriate management of polymicrobial infections. Diagnostic biomarkers for pathogenetically relevant processes occurring during BFI, including adhesion, development of hyphal structures, and mixed biofilm formation, are crucial for the development of new adjuvant therapy approaches complementing the use of established treatment strategies with antibiotic and antifungal drugs. Therapeutic interference with the communication between bacterial and fungal pathogens, as well as control of exacerbated inflammatory response, could be potential targets for improved control of specific polymicrobial infections. Novel therapeutic approaches targeting quorum sensing and microbial metabolites may be devised to tackle both bacterial and fungal infections [<xref ref-type="bibr" rid="B87-microorganisms-07-00459">87</xref>,<xref ref-type="bibr" rid="B88-microorganisms-07-00459">88</xref>,<xref ref-type="bibr" rid="B89-microorganisms-07-00459">89</xref>,<xref ref-type="bibr" rid="B90-microorganisms-07-00459">90</xref>,<xref ref-type="bibr" rid="B91-microorganisms-07-00459">91</xref>,<xref ref-type="bibr" rid="B92-microorganisms-07-00459">92</xref>,<xref ref-type="bibr" rid="B93-microorganisms-07-00459">93</xref>,<xref ref-type="bibr" rid="B94-microorganisms-07-00459">94</xref>,<xref ref-type="bibr" rid="B95-microorganisms-07-00459">95</xref>] in combination with antibiotic and antifungal drugs to enhance the efficacy of treatment [<xref ref-type="bibr" rid="B96-microorganisms-07-00459">96</xref>,<xref ref-type="bibr" rid="B97-microorganisms-07-00459">97</xref>,<xref ref-type="bibr" rid="B98-microorganisms-07-00459">98</xref>]. New insights acquired in this field will expectedly pave the way for more efficient personalized treatment strategies.</p>
</sec>
</body>
<back>
<notes>
<title>Author Contributions</title>
<p>F.N. and S.S. prepared the figures and wrote the manuscript. K.K. and T.L. provided input and edited the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>This work was supported by the European Commission within the FP7 Framework Programme [Fungitect-Grant No 602125] to T.L. and K.K.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors have declared that no competing interests exist.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-microorganisms-07-00459">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neely</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Law</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Holder</surname>
<given-names>I.A.</given-names>
</name>
</person-group>
<article-title>Increased susceptibility to lethal <italic>Candida</italic> infections in burned mice preinfected with <italic>Pseudomonas aeruginosa</italic> or pretreated with proteolytic enzymes</article-title>
<source/>Infect. Immun.
          <year>1986</year>
<volume>52</volume>
<fpage>200</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="pmid">2420722</pub-id>
</element-citation>
</ref>
<ref id="B2-microorganisms-07-00459">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergeron</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Seman</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Archambault</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Wheeler</surname>
<given-names>R.T.</given-names>
</name>
</person-group>
<article-title><italic>Candida</italic> and <italic>Pseudomonas</italic> interact to enhance virulence of mucosal infection in transparent zebrafish</article-title>
<source/>Infect. Immun.
          <year>2017</year>
<pub-id pub-id-type="doi">10.1128/IAI.00475-17</pub-id>
</element-citation>
</ref>
<ref id="B3-microorganisms-07-00459">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Risk factors for and clinical implications of mixed <italic>Candida</italic>/bacterial bloodstream infections</article-title>
<source/>Clin. Microbiol. Infect.
          <year>2013</year>
<volume>19</volume>
<fpage>62</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-0691.2012.03906.x</pub-id>
<pub-id pub-id-type="pmid">22651822</pub-id>
</element-citation>
</ref>
<ref id="B4-microorganisms-07-00459">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wargo</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Fungal--bacterial interactions: a mixed bag of mingling microbes</article-title>
<source/>Curr. Opin. Microbiol.
          <year>2006</year>
<volume>9</volume>
<fpage>359</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1016/j.mib.2006.06.001</pub-id>
<pub-id pub-id-type="pmid">16777473</pub-id>
</element-citation>
</ref>
<ref id="B5-microorganisms-07-00459">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Jabra-Rizk</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>O’May</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Costerton</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Shirtliff</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Polymicrobial interactions: impact on pathogenesis and human disease</article-title>
<source/>Clin. Microbiol. Rev.
          <year>2012</year>
<volume>25</volume>
<fpage>193</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.00013-11</pub-id>
<pub-id pub-id-type="pmid">22232376</pub-id>
</element-citation>
</ref>
<ref id="B6-microorganisms-07-00459">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz</surname>
<given-names>P.I.</given-names>
</name>
<name>
<surname>Strausbaugh</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Dongari-Bagtzoglou</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench</article-title>
<source/>Front. Cell. Infect. Microbiol.
          <year>2014</year>
<volume>4</volume>
<fpage>101</fpage>
<pub-id pub-id-type="doi">10.3389/fcimb.2014.00101</pub-id>
<pub-id pub-id-type="pmid">25120959</pub-id>
</element-citation>
</ref>
<ref id="B7-microorganisms-07-00459">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hermann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Munzel</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Ruchel</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Bacterial flora accompanying <italic>Candida</italic> yeasts in clinical specimens</article-title>
<source/>Mycoses
          <year>1999</year>
<volume>42</volume>
<fpage>619</fpage>
<lpage>627</lpage>
<pub-id pub-id-type="doi">10.1046/j.1439-0507.1999.00519.x</pub-id>
<pub-id pub-id-type="pmid">10680438</pub-id>
</element-citation>
</ref>
<ref id="B8-microorganisms-07-00459">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morales</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> interactions with bacteria in the context of human health and disease</article-title>
<source/>Plos Pathog.
          <year>2010</year>
<volume>6</volume>
<elocation-id>1000886</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1000886</pub-id>
</element-citation>
</ref>
<ref id="B9-microorganisms-07-00459">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kett</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Azoulay</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Echeverria</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title><italic>Candida</italic> bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study</article-title>
<source/>Crit. Care. Med.
          <year>2011</year>
<volume>39</volume>
<fpage>665</fpage>
<lpage>670</lpage>
<pub-id pub-id-type="doi">10.1097/CCM.0b013e318206c1ca</pub-id>
<pub-id pub-id-type="pmid">21169817</pub-id>
</element-citation>
</ref>
<ref id="B10-microorganisms-07-00459">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thorn</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Gilchrist</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Sobonya</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Gaur</surname>
<given-names>N.K.</given-names>
</name>
<name>
<surname>Lipke</surname>
<given-names>P.N.</given-names>
</name>
<name>
<surname>Klotz</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Postmortem Candidemia: Marker of disseminated disease</article-title>
<source/>J. Clin. Pathol.
          <year>2010</year>
<volume>63</volume>
<fpage>337</fpage>
<lpage>340</lpage>
<pub-id pub-id-type="doi">10.1136/jcp.2009.070607</pub-id>
<pub-id pub-id-type="pmid">19939858</pub-id>
</element-citation>
</ref>
<ref id="B11-microorganisms-07-00459">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Sordi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Muhlschlegel</surname>
<given-names>F.A.</given-names>
</name>
</person-group>
<article-title>Quorum sensing and fungal-bacterial interactions in <italic>Candida albicans</italic>: A communicative network regulating microbial coexistence and virulence</article-title>
<source/>Fems Yeast Res.
          <year>2009</year>
<volume>9</volume>
<fpage>990</fpage>
<lpage>999</lpage>
<pub-id pub-id-type="doi">10.1111/j.1567-1364.2009.00573.x</pub-id>
<pub-id pub-id-type="pmid">19845041</pub-id>
</element-citation>
</ref>
<ref id="B12-microorganisms-07-00459">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dixon</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infections</article-title>
<source/>Cell Microbiol.
          <year>2015</year>
<volume>17</volume>
<fpage>1431</fpage>
<lpage>1441</lpage>
<pub-id pub-id-type="doi">10.1111/cmi.12490</pub-id>
<pub-id pub-id-type="pmid">26243526</pub-id>
</element-citation>
</ref>
<ref id="B13-microorganisms-07-00459">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braga</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Dourado</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Araujo</surname>
<given-names>W.L.</given-names>
</name>
</person-group>
<article-title>Microbial interactions: ecology in a molecular perspective</article-title>
<source/>Braz. J. Microbiol.
          <year>2016</year>
<volume>47</volume>
<fpage>86</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1016/j.bjm.2016.10.005</pub-id>
<pub-id pub-id-type="pmid">27825606</pub-id>
</element-citation>
</ref>
<ref id="B14-microorganisms-07-00459">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischbach</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Microbiome: Focus on Causation and Mechanism</article-title>
<source/>Cell
          <year>2018</year>
<volume>174</volume>
<fpage>785</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2018.07.038</pub-id>
<pub-id pub-id-type="pmid">30096310</pub-id>
</element-citation>
</ref>
<ref id="B15-microorganisms-07-00459">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knight</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vrbanac</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Aksenov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Callewaert</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Debelius</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kosciolek</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>McCall</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Best practices for analysing microbiomes</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2018</year>
<volume>16</volume>
<fpage>410</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1038/s41579-018-0029-9</pub-id>
<pub-id pub-id-type="pmid">29795328</pub-id>
</element-citation>
</ref>
<ref id="B16-microorganisms-07-00459">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrett</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Cancer and the microbiota</article-title>
<source/>Science
          <year>2015</year>
<volume>348</volume>
<fpage>80</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1126/science.aaa4972</pub-id>
<pub-id pub-id-type="pmid">25838377</pub-id>
</element-citation>
</ref>
<ref id="B17-microorganisms-07-00459">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kruger</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Vielreicher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kapitan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>I.D.</given-names>
</name>
<name>
<surname>Niemiec</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Fungal-Bacterial Interactions in Health and Disease</article-title>
<source/>Pathogens
          <year>2019</year>
<volume>8</volume>
<elocation-id>70</elocation-id>
<pub-id pub-id-type="doi">10.3390/pathogens8020070</pub-id>
<pub-id pub-id-type="pmid">31117285</pub-id>
</element-citation>
</ref>
<ref id="B18-microorganisms-07-00459">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marsland</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Gollwitzer</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>Host-microorganism interactions in lung diseases</article-title>
<source/>Nat. Rev. Immunol.
          <year>2014</year>
<volume>14</volume>
<fpage>827</fpage>
<lpage>835</lpage>
<pub-id pub-id-type="doi">10.1038/nri3769</pub-id>
<pub-id pub-id-type="pmid">25421702</pub-id>
</element-citation>
</ref>
<ref id="B19-microorganisms-07-00459">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nash</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Auchtung</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Gesell</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Metcalf</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Muzny</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>R.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut mycobiome of the Human Microbiome Project healthy cohort</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<fpage>153</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-017-0373-4</pub-id>
<pub-id pub-id-type="pmid">29178920</pub-id>
</element-citation>
</ref>
<ref id="B20-microorganisms-07-00459">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witherden</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Shoaie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Moyes</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>The Human Mucosal Mycobiome and Fungal Community Interactions</article-title>
<source/>J. Fungi (Basel)
          <year>2017</year>
<volume>3</volume>
<elocation-id>56</elocation-id>
<pub-id pub-id-type="doi">10.3390/jof3040056</pub-id>
</element-citation>
</ref>
<ref id="B21-microorganisms-07-00459">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jo</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>H.H.</given-names>
</name>
</person-group>
<article-title>Topographical and physiological differences of the skin mycobiome in health and disease</article-title>
<source/>Virulence
          <year>2017</year>
<volume>8</volume>
<fpage>324</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="doi">10.1080/21505594.2016.1249093</pub-id>
<pub-id pub-id-type="pmid">27754756</pub-id>
</element-citation>
</ref>
<ref id="B22-microorganisms-07-00459">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Statovci</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Aguilera</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>MacSharry</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Melgar</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces</article-title>
<source/>Front. Immunol.
          <year>2017</year>
<volume>8</volume>
<fpage>838</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2017.00838</pub-id>
<pub-id pub-id-type="pmid">28804483</pub-id>
</element-citation>
</ref>
<ref id="B23-microorganisms-07-00459">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
</person-group>
<article-title>Minireview: Gut microbiota: the neglected endocrine organ</article-title>
<source/>Mol. Endocrinol.
          <year>2014</year>
<volume>28</volume>
<fpage>1221</fpage>
<lpage>1238</lpage>
<pub-id pub-id-type="doi">10.1210/me.2014-1108</pub-id>
<pub-id pub-id-type="pmid">24892638</pub-id>
</element-citation>
</ref>
<ref id="B24-microorganisms-07-00459">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hand</surname>
<given-names>T.W.</given-names>
</name>
</person-group>
<article-title>Role of the microbiota in immunity and inflammation</article-title>
<source/>Cell
          <year>2014</year>
<volume>157</volume>
<fpage>121</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.03.011</pub-id>
<pub-id pub-id-type="pmid">24679531</pub-id>
</element-citation>
</ref>
<ref id="B25-microorganisms-07-00459">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caballero</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pamer</surname>
<given-names>E.G.</given-names>
</name>
</person-group>
<article-title>Microbiota-mediated inflammation and antimicrobial defense in the intestine</article-title>
<source/>Annu. Rev. Immunol.
          <year>2015</year>
<volume>33</volume>
<fpage>227</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120238</pub-id>
<pub-id pub-id-type="pmid">25581310</pub-id>
</element-citation>
</ref>
<ref id="B26-microorganisms-07-00459">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selber-Hnatiw</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rukundo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akoubi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Al-Bizri</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Aliu</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Ambeaghen</surname>
<given-names>T.U.</given-names>
</name>
<name>
<surname>Avetisyan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bahar</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Human Gut Microbiota: Toward an Ecology of Disease</article-title>
<source/>Front. Microbiol.
          <year>2017</year>
<volume>8</volume>
<fpage>1265</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.01265</pub-id>
<pub-id pub-id-type="pmid">28769880</pub-id>
</element-citation>
</ref>
<ref id="B27-microorganisms-07-00459">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tojo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suarez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Clemente</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>de los Reyes-Gavilan</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Margolles</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gueimonde</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruas-Madiedo</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis</article-title>
<source/>World J. Gastroenterol.
          <year>2014</year>
<volume>20</volume>
<fpage>15163</fpage>
<lpage>15176</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v20.i41.15163</pub-id>
<pub-id pub-id-type="pmid">25386066</pub-id>
</element-citation>
</ref>
<ref id="B28-microorganisms-07-00459">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Candela</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Turroni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Biagi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Carbonero</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rampelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fiorentini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brigidi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Inflammation and colorectal cancer, when microbiota-host mutualism breaks</article-title>
<source/>World J. Gastroenterol.
          <year>2014</year>
<volume>20</volume>
<fpage>908</fpage>
<lpage>922</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v20.i4.908</pub-id>
<pub-id pub-id-type="pmid">24574765</pub-id>
</element-citation>
</ref>
<ref id="B29-microorganisms-07-00459">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galloway-Pena</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brumlow</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shelburne</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Impact of the Microbiota on Bacterial Infections during Cancer Treatment</article-title>
<source/>Trends Microbiol.
          <year>2017</year>
<volume>25</volume>
<fpage>992</fpage>
<lpage>1004</lpage>
<pub-id pub-id-type="doi">10.1016/j.tim.2017.06.006</pub-id>
<pub-id pub-id-type="pmid">28728967</pub-id>
</element-citation>
</ref>
<ref id="B30-microorganisms-07-00459">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heisel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Montassier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Al-Ghalith</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Knights</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gale</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut</article-title>
<source/>mSphere
          <year>2017</year>
<volume>2</volume>
<pub-id pub-id-type="doi">10.1128/mSphere.00351-17</pub-id>
</element-citation>
</ref>
<ref id="B31-microorganisms-07-00459">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lof</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Janus</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Krom</surname>
<given-names>B.P.</given-names>
</name>
</person-group>
<article-title>Metabolic Interactions between Bacteria and Fungi in Commensal Oral Biofilms</article-title>
<source/>J. Fungi (Basel)
          <year>2017</year>
<volume>3</volume>
<elocation-id>40</elocation-id>
<pub-id pub-id-type="doi">10.3390/jof3030040</pub-id>
</element-citation>
</ref>
<ref id="B32-microorganisms-07-00459">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raskov</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Burcharth</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pommergaard</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Linking Gut Microbiota to Colorectal Cancer</article-title>
<source/>J. Cancer
          <year>2017</year>
<volume>8</volume>
<fpage>3378</fpage>
<lpage>3395</lpage>
<pub-id pub-id-type="doi">10.7150/jca.20497</pub-id>
<pub-id pub-id-type="pmid">29151921</pub-id>
</element-citation>
</ref>
<ref id="B33-microorganisms-07-00459">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsilimigras</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Fodor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jobin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Carcinogenesis and therapeutics: the microbiota perspective</article-title>
<source/>Nat. Microbiol.
          <year>2017</year>
<volume>2</volume>
<fpage>17008</fpage>
<pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.8</pub-id>
<pub-id pub-id-type="pmid">28225000</pub-id>
</element-citation>
</ref>
<ref id="B34-microorganisms-07-00459">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zitvogel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Daillere</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Roberti</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Routy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Anticancer effects of the microbiome and its products</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2017</year>
<volume>15</volume>
<fpage>465</fpage>
<lpage>478</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2017.44</pub-id>
<pub-id pub-id-type="pmid">28529325</pub-id>
</element-citation>
</ref>
<ref id="B35-microorganisms-07-00459">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwabe</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Jobin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The microbiome and cancer</article-title>
<source/>Nat. Rev. Cancer
          <year>2013</year>
<volume>13</volume>
<fpage>800</fpage>
<lpage>812</lpage>
<pub-id pub-id-type="doi">10.1038/nrc3610</pub-id>
<pub-id pub-id-type="pmid">24132111</pub-id>
</element-citation>
</ref>
<ref id="B36-microorganisms-07-00459">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liguori</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lamas</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Richard</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Brandi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>da Costa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Di Simone</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Poggioli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Langella</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn’s Disease Patients</article-title>
<source/>J. Crohns. Colitis.
          <year>2016</year>
<volume>10</volume>
<fpage>296</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1093/ecco-jcc/jjv209</pub-id>
<pub-id pub-id-type="pmid">26574491</pub-id>
</element-citation>
</ref>
<ref id="B37-microorganisms-07-00459">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pope</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Tomkovich</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jobin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Microbiota as a mediator of cancer progression and therapy</article-title>
<source/>Transl. Res.
          <year>2017</year>
<volume>179</volume>
<fpage>139</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1016/j.trsl.2016.07.021</pub-id>
<pub-id pub-id-type="pmid">27554797</pub-id>
</element-citation>
</ref>
<ref id="B38-microorganisms-07-00459">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagniere</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Raisch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Veziant</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Barnich</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bonnet</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Buc</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bringer</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Pezet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bonnet</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Gut microbiota imbalance and colorectal cancer</article-title>
<source/>World J. Gastroenterol.
          <year>2016</year>
<volume>22</volume>
<fpage>501</fpage>
<lpage>518</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v22.i2.501</pub-id>
<pub-id pub-id-type="pmid">26811603</pub-id>
</element-citation>
</ref>
<ref id="B39-microorganisms-07-00459">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeGruttola</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Current Understanding of Dysbiosis in Disease in Human and Animal Models</article-title>
<source/>Inflamm. Bowel Dis.
          <year>2016</year>
<volume>22</volume>
<fpage>1137</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="doi">10.1097/MIB.0000000000000750</pub-id>
<pub-id pub-id-type="pmid">27070911</pub-id>
</element-citation>
</ref>
<ref id="B40-microorganisms-07-00459">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Gnotobiotics</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2014</year>
<volume>111</volume>
<fpage>1661</fpage>
<pub-id pub-id-type="doi">10.1073/pnas.1324049111</pub-id>
<pub-id pub-id-type="pmid">24497491</pub-id>
</element-citation>
</ref>
<ref id="B41-microorganisms-07-00459">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Pesti</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The gnotobiotic animal as a tool in the study of host microbial relationships</article-title>
<source/>Bacteriol. Rev.
          <year>1971</year>
<volume>35</volume>
<fpage>390</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="pmid">4945725</pub-id>
</element-citation>
</ref>
<ref id="B42-microorganisms-07-00459">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Ridaura</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Faith</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J.I.</given-names>
</name>
</person-group>
<article-title>The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice</article-title>
<source/>Sci. Transl. Med.
          <year>2009</year>
<volume>1</volume>
<fpage>6ra14</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3000322</pub-id>
<pub-id pub-id-type="pmid">20368178</pub-id>
</element-citation>
</ref>
<ref id="B43-microorganisms-07-00459">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gill</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Pop</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Deboy</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Eckburg</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Turnbaugh</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Relman</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Fraser-Liggett</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>K.E.</given-names>
</name>
</person-group>
<article-title>Metagenomic analysis of the human distal gut microbiome</article-title>
<source/>Science
          <year>2006</year>
<volume>312</volume>
<fpage>1355</fpage>
<lpage>1359</lpage>
<pub-id pub-id-type="doi">10.1126/science.1124234</pub-id>
<pub-id pub-id-type="pmid">16741115</pub-id>
</element-citation>
</ref>
<ref id="B44-microorganisms-07-00459">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Mahowald</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Magrini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mardis</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J.I.</given-names>
</name>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>Nature
          <year>2006</year>
<volume>444</volume>
<fpage>1027</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="doi">10.1038/nature05414</pub-id>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="B45-microorganisms-07-00459">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Backhed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hooper</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>G.Y.</given-names>
</name>
<name>
<surname>Nagy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Semenkovich</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J.I.</given-names>
</name>
</person-group>
<article-title>The gut microbiota as an environmental factor that regulates fat storage</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>15718</fpage>
<lpage>15723</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0407076101</pub-id>
<pub-id pub-id-type="pmid">15505215</pub-id>
</element-citation>
</ref>
<ref id="B46-microorganisms-07-00459">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cash</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Whitham</surname>
<given-names>C.V.</given-names>
</name>
<name>
<surname>Behrendt</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Hooper</surname>
<given-names>L.V.</given-names>
</name>
</person-group>
<article-title>Symbiotic bacteria direct expression of an intestinal bactericidal lectin</article-title>
<source/>Science
          <year>2006</year>
<volume>313</volume>
<fpage>1126</fpage>
<lpage>1130</lpage>
<pub-id pub-id-type="doi">10.1126/science.1127119</pub-id>
<pub-id pub-id-type="pmid">16931762</pub-id>
</element-citation>
</ref>
<ref id="B47-microorganisms-07-00459">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umesaki</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Use of gnotobiotic mice to identify and characterize key microbes responsible for the development of the intestinal immune system</article-title>
<source/>Proc. Jpn. Acad. Ser. B.
          <year>2014</year>
<volume>90</volume>
<fpage>313</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.2183/pjab.90.313</pub-id>
<pub-id pub-id-type="pmid">25391317</pub-id>
</element-citation>
</ref>
<ref id="B48-microorganisms-07-00459">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burmolle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bjarnsholt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Interactions in multispecies biofilms: do they actually matter?</article-title>
<source/>Trends Microbiol.
          <year>2014</year>
<volume>22</volume>
<fpage>84</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.tim.2013.12.004</pub-id>
<pub-id pub-id-type="pmid">24440178</pub-id>
</element-citation>
</ref>
<ref id="B49-microorganisms-07-00459">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Vos</surname>
<given-names>W.M.</given-names>
</name>
</person-group>
<article-title>Microbial biofilms and the human intestinal microbiome</article-title>
<source/>Npj Biofilms Microbiomes
          <year>2015</year>
<volume>1</volume>
<fpage>15005</fpage>
<pub-id pub-id-type="doi">10.1038/npjbiofilms.2015.5</pub-id>
<pub-id pub-id-type="pmid">28721229</pub-id>
</element-citation>
</ref>
<ref id="B50-microorganisms-07-00459">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raskov</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kragh</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Bjarnsholt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Alamili</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gogenur</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Bacterial biofilm formation inside colonic crypts may accelerate colorectal carcinogenesis</article-title>
<source/>Clin. Transl. Med.
          <year>2018</year>
<volume>7</volume>
<fpage>018</fpage>
<lpage>0209</lpage>
<pub-id pub-id-type="doi">10.1186/s40169-018-0209-2</pub-id>
</element-citation>
</ref>
<ref id="B51-microorganisms-07-00459">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leclair</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Mixed bacterial-fungal infections in the, C.F. respiratory tract</article-title>
<source/>Med. Mycol.
          <year>2010</year>
<volume>48</volume>
<fpage>521522</fpage>
<pub-id pub-id-type="doi">10.3109/13693786.2010.521522</pub-id>
</element-citation>
</ref>
<ref id="B52-microorganisms-07-00459">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chotirmall</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>O’Donoghue</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gunaratnam</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>O’Neill</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>McElvaney</surname>
<given-names>N.G.</given-names>
</name>
</person-group>
<article-title>Sputum <italic>Candida albicans</italic> presages, F.E.V(1) decline and hospital-treated exacerbations in cystic fibrosis</article-title>
<source/>Chest
          <year>2010</year>
<volume>138</volume>
<fpage>1186</fpage>
<lpage>1195</lpage>
<pub-id pub-id-type="doi">10.1378/chest.09-2996</pub-id>
<pub-id pub-id-type="pmid">20472859</pub-id>
</element-citation>
</ref>
<ref id="B53-microorganisms-07-00459">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reece</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Segurado</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McClean</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Renwick</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Greally</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Co-colonisation with <italic>Aspergillus fumigatus</italic> and <italic>Pseudomonas aeruginosa</italic> is associated with poorer health in cystic fibrosis patients: an Irish registry analysis</article-title>
<source/>BMC Pulm. Med.
          <year>2017</year>
<volume>17</volume>
<elocation-id>70</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12890-017-0416-4</pub-id>
<pub-id pub-id-type="pmid">28431569</pub-id>
</element-citation>
</ref>
<ref id="B54-microorganisms-07-00459">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujimura</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Sitarik</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Havstad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Levan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fadrosh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Panzer</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>LaMere</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rackaityte</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lukacs</surname>
<given-names>N.W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation</article-title>
<source/>Nat. Med.
          <year>2016</year>
<volume>22</volume>
<fpage>1187</fpage>
<lpage>1191</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4176</pub-id>
<pub-id pub-id-type="pmid">27618652</pub-id>
</element-citation>
</ref>
<ref id="B55-microorganisms-07-00459">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arrieta</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Stiemsma</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Dimitriu</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Thorson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yurist-Doutsch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kuzeljevic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gold</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Britton</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>D.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early infancy microbial and metabolic alterations affect risk of childhood asthma</article-title>
<source/>Sci. Transl. Med.
          <year>2015</year>
<volume>7</volume>
<fpage>307ra152</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.aab2271</pub-id>
</element-citation>
</ref>
<ref id="B56-microorganisms-07-00459">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobel</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Vulvovaginal candidosis</article-title>
<source/>Lancet
          <year>2007</year>
<volume>369</volume>
<fpage>1961</fpage>
<lpage>1971</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(07)60917-9</pub-id>
<pub-id pub-id-type="pmid">17560449</pub-id>
</element-citation>
</ref>
<ref id="B57-microorganisms-07-00459">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Wijgert</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Borgdorff</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Verhelst</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Crucitti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verstraelen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jespers</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>The vaginal microbiota: what have we learned after a decade of molecular characterization?</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e105998</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0105998</pub-id>
<pub-id pub-id-type="pmid">25148517</pub-id>
</element-citation>
</ref>
<ref id="B58-microorganisms-07-00459">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hall</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Noverr</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Fungal interactions with the human host: exploring the spectrum of symbiosis</article-title>
<source/>Curr. Opin. Microbiol.
          <year>2017</year>
<volume>40</volume>
<fpage>58</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.mib.2017.10.020</pub-id>
<pub-id pub-id-type="pmid">29132066</pub-id>
</element-citation>
</ref>
<ref id="B59-microorganisms-07-00459">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burd</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Endotoxin promotes synergistic lethality during concurrent <italic>Escherichia coli</italic> and <italic>Candida albicans</italic> infection</article-title>
<source/>J. Surg. Res.
          <year>1992</year>
<volume>52</volume>
<fpage>537</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1016/0022-4804(92)90125-J</pub-id>
<pub-id pub-id-type="pmid">1528027</pub-id>
</element-citation>
</ref>
<ref id="B60-microorganisms-07-00459">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikeda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suegara</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Efficacy of antibacterial drugs in mice with complex infection by <italic>Candida albicans</italic> and <italic>Escherichia coli</italic></article-title>
<source/>J. Antibiot.
          <year>1999</year>
<volume>52</volume>
<fpage>552</fpage>
<lpage>558</lpage>
<pub-id pub-id-type="doi">10.7164/antibiotics.52.552</pub-id>
<pub-id pub-id-type="pmid">10470680</pub-id>
</element-citation>
</ref>
<ref id="B61-microorganisms-07-00459">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Standaert-Vitse</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sendid</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Joossens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Francois</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vandewalle-El Khoury</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Branche</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Van Kruiningen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jouault</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rutgeerts</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gower-Rousseau</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Candida albicans</italic> colonization and, A.S.CA in familial Crohn’s disease</article-title>
<source/>Am. J. Gastroenterol.
          <year>2009</year>
<volume>104</volume>
<fpage>1745</fpage>
<lpage>1753</lpage>
<pub-id pub-id-type="doi">10.1038/ajg.2009.225</pub-id>
<pub-id pub-id-type="pmid">19471251</pub-id>
</element-citation>
</ref>
<ref id="B62-microorganisms-07-00459">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiaro</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Soto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zac Stephens</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kubinak</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gogokhia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Delgado</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Voth</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice</article-title>
<source/>Sci. Transl. Med.
          <year>2017</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1126/scitranslmed.aaf9044</pub-id>
<pub-id pub-id-type="pmid">28275154</pub-id>
</element-citation>
</ref>
<ref id="B63-microorganisms-07-00459">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>10416</fpage>
<pub-id pub-id-type="doi">10.1038/srep10416</pub-id>
<pub-id pub-id-type="pmid">26013555</pub-id>
</element-citation>
</ref>
<ref id="B64-microorganisms-07-00459">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noverr</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Noggle</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Toews</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Huffnagle</surname>
<given-names>G.B.</given-names>
</name>
</person-group>
<article-title>Role of antibiotics and fungal microbiota in driving pulmonary allergic responses</article-title>
<source/>Infect. Immun.
          <year>2004</year>
<volume>72</volume>
<fpage>4996</fpage>
<lpage>5003</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.72.9.4996-5003.2004</pub-id>
<pub-id pub-id-type="pmid">15321991</pub-id>
</element-citation>
</ref>
<ref id="B65-microorganisms-07-00459">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheeler</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Limon</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Bar</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Leal</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Gargus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Funari</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Crother</surname>
<given-names>T.R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunological Consequences of Intestinal Fungal Dysbiosis</article-title>
<source/>Cell Host Microbe.
          <year>2016</year>
<volume>19</volume>
<fpage>865</fpage>
<lpage>873</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2016.05.003</pub-id>
<pub-id pub-id-type="pmid">27237365</pub-id>
</element-citation>
</ref>
<ref id="B66-microorganisms-07-00459">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sommer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Backhed</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The gut microbiota--masters of host development and physiology</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2013</year>
<volume>11</volume>
<fpage>227</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2974</pub-id>
<pub-id pub-id-type="pmid">23435359</pub-id>
</element-citation>
</ref>
<ref id="B67-microorganisms-07-00459">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gurav</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sivaprakasam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Padia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Thangaraju</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Manicassamy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Munn</surname>
<given-names>D.H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis</article-title>
<source/>Immunity
          <year>2014</year>
<volume>40</volume>
<fpage>128</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2013.12.007</pub-id>
<pub-id pub-id-type="pmid">24412617</pub-id>
</element-citation>
</ref>
<ref id="B68-microorganisms-07-00459">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Flint</surname>
<given-names>H.J.</given-names>
</name>
</person-group>
<article-title>Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine</article-title>
<source/>FEMS Microbiol. Lett.
          <year>2009</year>
<volume>294</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01514.x</pub-id>
<pub-id pub-id-type="pmid">19222573</pub-id>
</element-citation>
</ref>
<ref id="B69-microorganisms-07-00459">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mack</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stintzi</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease</article-title>
<source/>Inflamm. Bowel Dis.
          <year>2015</year>
<volume>21</volume>
<fpage>139</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="doi">10.1097/MIB.0000000000000215</pub-id>
<pub-id pub-id-type="pmid">25248007</pub-id>
</element-citation>
</ref>
<ref id="B70-microorganisms-07-00459">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sam</surname>
<given-names>Q.H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>L.Y.</given-names>
</name>
</person-group>
<article-title>The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host</article-title>
<source/>Int. J. Mol. Sci.
          <year>2017</year>
<volume>18</volume>
<elocation-id>330</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms18020330</pub-id>
</element-citation>
</ref>
<ref id="B71-microorganisms-07-00459">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>G.C.</given-names>
</name>
</person-group>
<article-title>Editorial: bugs and drugs: insights into the pathogenesis of inflammatory bowel disease</article-title>
<source/>Am. J. Gastroenterol.
          <year>2011</year>
<volume>106</volume>
<fpage>2143</fpage>
<lpage>2145</lpage>
<pub-id pub-id-type="doi">10.1038/ajg.2011.308</pub-id>
<pub-id pub-id-type="pmid">22138941</pub-id>
</element-citation>
</ref>
<ref id="B72-microorganisms-07-00459">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schulz</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Atay</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heringer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Romrig</surname>
<given-names>F.K.</given-names>
</name>
<name>
<surname>Schwitalla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aydin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Reindl</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pommerenke</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity</article-title>
<source/>Nature
          <year>2014</year>
<volume>514</volume>
<fpage>508</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="doi">10.1038/nature13398</pub-id>
<pub-id pub-id-type="pmid">25174708</pub-id>
</element-citation>
</ref>
<ref id="B73-microorganisms-07-00459">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belcheva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Irrazabal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Streutker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maughan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rubino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moriyama</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Copeland</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Surendra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbial metabolism drives transformation of, M.S.H2-deficient colon epithelial cells</article-title>
<source/>Cell
          <year>2014</year>
<volume>158</volume>
<fpage>288</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.04.051</pub-id>
<pub-id pub-id-type="pmid">25036629</pub-id>
</element-citation>
</ref>
<ref id="B74-microorganisms-07-00459">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupton</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Microbial degradation products influence colon cancer risk: the butyrate controversy</article-title>
<source/>J. Nutr.
          <year>2004</year>
<volume>134</volume>
<fpage>479</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1093/jn/134.2.479</pub-id>
<pub-id pub-id-type="pmid">14747692</pub-id>
</element-citation>
</ref>
<ref id="B75-microorganisms-07-00459">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmer</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Aye</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Whiteley</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Nutritional cues control <italic>Pseudomonas aeruginosa</italic> multicellular behavior in cystic fibrosis sputum</article-title>
<source/>J. Bacteriol.
          <year>2007</year>
<volume>189</volume>
<fpage>8079</fpage>
<lpage>8087</lpage>
<pub-id pub-id-type="doi">10.1128/JB.01138-07</pub-id>
<pub-id pub-id-type="pmid">17873029</pub-id>
</element-citation>
</ref>
<ref id="B76-microorganisms-07-00459">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gainza-Cirauqui</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Nieminen</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Novak Frazer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Aguirre-Urizar</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Moragues</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Rautemaa</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Production of carcinogenic acetaldehyde by <italic>Candida albicans</italic> from patients with potentially malignant oral mucosal disorders</article-title>
<source/>J. Oral Pathol. Med.
          <year>2013</year>
<volume>42</volume>
<fpage>243</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0714.2012.01203.x</pub-id>
<pub-id pub-id-type="pmid">22909057</pub-id>
</element-citation>
</ref>
<ref id="B77-microorganisms-07-00459">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meurman</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Uittamo</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Oral micro-organisms in the etiology of cancer</article-title>
<source/>Acta. Odontol. Scand.
          <year>2008</year>
<volume>66</volume>
<fpage>321</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1080/00016350802446527</pub-id>
<pub-id pub-id-type="pmid">18821087</pub-id>
</element-citation>
</ref>
<ref id="B78-microorganisms-07-00459">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whiteley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Diggle</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>E.P.</given-names>
</name>
</person-group>
<article-title>Progress in and promise of bacterial quorum sensing research</article-title>
<source/>Nature
          <year>2017</year>
<volume>551</volume>
<fpage>313</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1038/nature24624</pub-id>
<pub-id pub-id-type="pmid">29144467</pub-id>
</element-citation>
</ref>
<ref id="B79-microorganisms-07-00459">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rio</surname>
<given-names>R.V.M.</given-names>
</name>
</person-group>
<article-title>Don’t Bite the Hand that Feeds You</article-title>
<source/>Cell Host Microbe.
          <year>2017</year>
<volume>21</volume>
<fpage>552</fpage>
<lpage>554</lpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2017.04.013</pub-id>
<pub-id pub-id-type="pmid">28494233</pub-id>
</element-citation>
</ref>
<ref id="B80-microorganisms-07-00459">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>I.D.</given-names>
</name>
</person-group>
<article-title>Quorum sensing by farnesol revisited</article-title>
<source/>Curr. Genet.
          <year>2017</year>
<volume>63</volume>
<fpage>791</fpage>
<lpage>797</lpage>
<pub-id pub-id-type="doi">10.1007/s00294-017-0683-x</pub-id>
<pub-id pub-id-type="pmid">28247023</pub-id>
</element-citation>
</ref>
<ref id="B81-microorganisms-07-00459">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papenfort</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bassler</surname>
<given-names>B.L.</given-names>
</name>
</person-group>
<article-title>Quorum sensing signal-response systems in Gram-negative bacteria</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2016</year>
<volume>14</volume>
<fpage>576</fpage>
<lpage>588</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2016.89</pub-id>
<pub-id pub-id-type="pmid">27510864</pub-id>
</element-citation>
</ref>
<ref id="B82-microorganisms-07-00459">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Toole</surname>
<given-names>G.A.</given-names>
</name>
</person-group>
<article-title>Classic Spotlight: Quorum Sensing and the Multicellular Life of Unicellular Organisms</article-title>
<source/>J. Bacteriol.
          <year>2016</year>
<volume>198</volume>
<fpage>601</fpage>
<pub-id pub-id-type="doi">10.1128/JB.00956-15</pub-id>
<pub-id pub-id-type="pmid">26825965</pub-id>
</element-citation>
</ref>
<ref id="B83-microorganisms-07-00459">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofer</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Biofilms: Turning tides for quorum sensing</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2016</year>
<volume>14</volume>
<fpage>64</fpage>
<pub-id pub-id-type="doi">10.1038/nrmicro.2015.26</pub-id>
<pub-id pub-id-type="pmid">26775922</pub-id>
</element-citation>
</ref>
<ref id="B84-microorganisms-07-00459">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pammi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mistretta</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Versalovic</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Biofilm extracellular, D.N.A enhances mixed species biofilms of <italic>Staphylococcus epidermidis</italic> and <italic>Candida albicans</italic></article-title>
<source/>BMC Microbiol.
          <year>2013</year>
<volume>13</volume>
<fpage>1471</fpage>
<lpage>2180</lpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-13-257</pub-id>
</element-citation>
</ref>
<ref id="B85-microorganisms-07-00459">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rajendran</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lappin</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title><italic>Aspergillus fumigatus</italic> enhances elastase production in <italic>Pseudomonas aeruginosa</italic> co-cultures</article-title>
<source/>Med. Mycol.
          <year>2015</year>
<volume>53</volume>
<fpage>645</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="doi">10.1093/mmy/myv048</pub-id>
<pub-id pub-id-type="pmid">26162475</pub-id>
</element-citation>
</ref>
<ref id="B86-microorganisms-07-00459">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mear</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Kipnis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dessein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schurtz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Guery</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> and <italic>Pseudomonas aeruginosa</italic> interactions: more than an opportunistic criminal association?</article-title>
<source/>Med. Mal. Infect.
          <year>2013</year>
<volume>43</volume>
<fpage>146</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="doi">10.1016/j.medmal.2013.02.005</pub-id>
<pub-id pub-id-type="pmid">23622953</pub-id>
</element-citation>
</ref>
<ref id="B87-microorganisms-07-00459">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>X.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Kjelleberg</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Community quorum sensing signalling and quenching: microbial granular biofilm assembly</article-title>
<source/>Npj Biofilms Microbiomes
          <year>2015</year>
<volume>1</volume>
<fpage>15006</fpage>
<pub-id pub-id-type="doi">10.1038/npjbiofilms.2015.6</pub-id>
<pub-id pub-id-type="pmid">28721230</pub-id>
</element-citation>
</ref>
<ref id="B88-microorganisms-07-00459">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>AiiA, an enzyme that inactivates the acylhomoserine lactone quorum-sensing signal and attenuates the virulence of <italic>Erwinia carotovora</italic></article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2000</year>
<volume>97</volume>
<fpage>3526</fpage>
<lpage>3531</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.97.7.3526</pub-id>
<pub-id pub-id-type="pmid">10716724</pub-id>
</element-citation>
</ref>
<ref id="B89-microorganisms-07-00459">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Defoirdt</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Quorum-Sensing Systems as Targets for Antivirulence Therapy</article-title>
<source/>Trends Microbiol.
          <year>2017</year>
<pub-id pub-id-type="doi">10.1016/j.tim.2017.10.005</pub-id>
</element-citation>
</ref>
<ref id="B90-microorganisms-07-00459">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abraham</surname>
<given-names>W.R.</given-names>
</name>
</person-group>
<article-title>Going beyond the Control of Quorum-Sensing to Combat Biofilm Infections</article-title>
<source/>Antibiotics (Basel)
          <year>2016</year>
<volume>5</volume>
<elocation-id>3</elocation-id>
<pub-id pub-id-type="doi">10.3390/antibiotics5010003</pub-id>
</element-citation>
</ref>
<ref id="B91-microorganisms-07-00459">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Djukovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ubeda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>K.B.</given-names>
</name>
</person-group>
<article-title>Manipulation of the quorum sensing signal, A.I.-2 affects the antibiotic-treated gut microbiota</article-title>
<source/>Cell Rep.
          <year>2015</year>
<volume>10</volume>
<fpage>1861</fpage>
<lpage>1871</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.02.049</pub-id>
<pub-id pub-id-type="pmid">25801025</pub-id>
</element-citation>
</ref>
<ref id="B92-microorganisms-07-00459">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Contreras</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Is Quorum Sensing Interference a Viable Alternative to Treat <italic>Pseudomonas aeruginosa</italic> Infections?</article-title>
<source/>Front. Microbiol.
          <year>2016</year>
<volume>7</volume>
<fpage>1454</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.01454</pub-id>
<pub-id pub-id-type="pmid">27683577</pub-id>
</element-citation>
</ref>
<ref id="B93-microorganisms-07-00459">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of <italic>Pseudomonas aeruginosa</italic></article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>19141</fpage>
<pub-id pub-id-type="doi">10.1038/srep19141</pub-id>
<pub-id pub-id-type="pmid">26751736</pub-id>
</element-citation>
</ref>
<ref id="B94-microorganisms-07-00459">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muimhneacháin</surname>
<given-names>E.Ó.</given-names>
</name>
<name>
<surname>Reen</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>O’Gara</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>McGlacken</surname>
<given-names>G.P.</given-names>
</name>
</person-group>
<article-title>Analogues of <italic>Pseudomonas aeruginosa</italic> signalling molecules to tackle infections</article-title>
<source/>Org. Biomol. Chem.
          <year>2018</year>
<volume>16</volume>
<fpage>169</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1039/C7OB02395B</pub-id>
<pub-id pub-id-type="pmid">29095463</pub-id>
</element-citation>
</ref>
<ref id="B95-microorganisms-07-00459">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gabrilska</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wessel</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Whiteley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rumbaugh</surname>
<given-names>K.P.</given-names>
</name>
</person-group>
<article-title>Albumin Inhibits <italic>Pseudomonas aeruginosa</italic> Quorum Sensing and Alters Polymicrobial Interactions</article-title>
<source/>Infect. Immun.
          <year>2017</year>
<volume>85</volume>
<fpage>116</fpage>
<pub-id pub-id-type="doi">10.1128/IAI.00116-17</pub-id>
</element-citation>
</ref>
<ref id="B96-microorganisms-07-00459">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imperi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Leoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Visca</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Antivirulence activity of azithromycin in <italic>Pseudomonas aeruginosa</italic></article-title>
<source/>Front. Microbiol.
          <year>2014</year>
<volume>5</volume>
<fpage>178</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2014.00178</pub-id>
<pub-id pub-id-type="pmid">24795709</pub-id>
</element-citation>
</ref>
<ref id="B97-microorganisms-07-00459">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramage</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Saville</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Wickes</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Lopez-Ribot</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Inhibition of <italic>Candida albicans</italic> Biofilm Formation by Farnesol, a Quorum-Sensing Molecule</article-title>
<source/>Appl. Environ. Microbiol.
          <year>2002</year>
<volume>68</volume>
<fpage>5459</fpage>
<lpage>5463</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.68.11.5459-5463.2002</pub-id>
<pub-id pub-id-type="pmid">12406738</pub-id>
</element-citation>
</ref>
<ref id="B98-microorganisms-07-00459">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cordeiro</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Brilhante</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Castelo-Branco</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Paiva</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Giffoni Leite</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>D.T.</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Sidrim</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against <italic>Candida</italic> species are reduced by farnesol</article-title>
<source/>Med. Mycol.
          <year>2013</year>
<volume>51</volume>
<fpage>53</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.3109/13693786.2012.692489</pub-id>
<pub-id pub-id-type="pmid">22712455</pub-id>
</element-citation>
</ref>
<ref id="B99-microorganisms-07-00459">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mear</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Gosset</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kipnis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dessein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jawhara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fradin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Poulain</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sendid</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Candida albicans</italic> airway exposure primes the lung innate immune response against <italic>Pseudomonas aeruginosa</italic> infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response</article-title>
<source/>Infect. Immun.
          <year>2014</year>
<volume>82</volume>
<fpage>306</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.01085-13</pub-id>
<pub-id pub-id-type="pmid">24166952</pub-id>
</element-citation>
</ref>
<ref id="B100-microorganisms-07-00459">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peleg</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Mylonakis</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Medically important bacterial-fungal interactions</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2010</year>
<volume>8</volume>
<fpage>340</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2313</pub-id>
<pub-id pub-id-type="pmid">20348933</pub-id>
</element-citation>
</ref>
<ref id="B101-microorganisms-07-00459">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sood</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title><italic>Pseudomonas aeruginosa</italic>-<italic>Candida albicans</italic> interactions: localization and fungal toxicity of a phenazine derivative</article-title>
<source/>Appl. Env. Microbiol.
          <year>2009</year>
<volume>75</volume>
<fpage>504</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.01037-08</pub-id>
<pub-id pub-id-type="pmid">19011064</pub-id>
</element-citation>
</ref>
<ref id="B102-microorganisms-07-00459">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Vik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kolter</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A <italic>Pseudomonas aeruginosa</italic> quorum-sensing molecule influences <italic>Candida albicans</italic> morphology</article-title>
<source/>Mol. Microbiol.
          <year>2004</year>
<volume>54</volume>
<fpage>1212</fpage>
<lpage>1223</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04349.x</pub-id>
<pub-id pub-id-type="pmid">15554963</pub-id>
</element-citation>
</ref>
<ref id="B103-microorganisms-07-00459">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Talking to themselves: autoregulation and quorum sensing in fungi</article-title>
<source/>Eukaryot. Cell.
          <year>2006</year>
<volume>5</volume>
<fpage>613</fpage>
<lpage>619</lpage>
<pub-id pub-id-type="doi">10.1128/EC.5.4.613-619.2006</pub-id>
<pub-id pub-id-type="pmid">16607008</pub-id>
</element-citation>
</ref>
<ref id="B104-microorganisms-07-00459">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purschke</surname>
<given-names>F.G.</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Trick</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rupp</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Flexible survival strategies of <italic>Pseudomonas aeruginosa</italic> in biofilms result in increased fitness compared with <italic>Candida albicans</italic></article-title>
<source/>Mol. Cell Proteomics.
          <year>2012</year>
<volume>11</volume>
<fpage>1652</fpage>
<lpage>1669</lpage>
<pub-id pub-id-type="doi">10.1074/mcp.M112.017673</pub-id>
<pub-id pub-id-type="pmid">22942357</pub-id>
</element-citation>
</ref>
<ref id="B105-microorganisms-07-00459">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerr</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Suppression of fungal growth exhibited by <italic>Pseudomonas aeruginosa</italic></article-title>
<source/>J. Clin. Microbiol.
          <year>1994</year>
<volume>32</volume>
<fpage>525</fpage>
<lpage>527</lpage>
<pub-id pub-id-type="pmid">8150966</pub-id>
</element-citation>
</ref>
<ref id="B106-microorganisms-07-00459">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerr</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Rutman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hoiby</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title><italic>Pseudomonas aeruginosa</italic> pyocyanin and 1-hydroxyphenazine inhibit fungal growth</article-title>
<source/>J. Clin. Pathol.
          <year>1999</year>
<volume>52</volume>
<fpage>385</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1136/jcp.52.5.385</pub-id>
<pub-id pub-id-type="pmid">10560362</pub-id>
</element-citation>
</ref>
<ref id="B107-microorganisms-07-00459">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charlton</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>de Nys</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Netting</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hentzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Givskov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kjelleberg</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>A novel and sensitive method for the quantification of N-3-oxoacyl homoserine lactones using gas chromatography-mass spectrometry: application to a model bacterial biofilm</article-title>
<source/>Env. Microbiol.
          <year>2000</year>
<volume>2</volume>
<fpage>530</fpage>
<lpage>541</lpage>
<pub-id pub-id-type="doi">10.1046/j.1462-2920.2000.00136.x</pub-id>
<pub-id pub-id-type="pmid">11233161</pub-id>
</element-citation>
</ref>
<ref id="B108-microorganisms-07-00459">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Kolter</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title><italic>Pseudomonas</italic>-<italic>Candida</italic> interactions: an ecological role for virulence factors</article-title>
<source/>Science
          <year>2002</year>
<volume>296</volume>
<fpage>2229</fpage>
<lpage>2232</lpage>
<pub-id pub-id-type="doi">10.1126/science.1070784</pub-id>
<pub-id pub-id-type="pmid">12077418</pub-id>
</element-citation>
</ref>
<ref id="B109-microorganisms-07-00459">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cugini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Calfee</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Farrow</surname>
<given-names>J.M.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Morales</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Pesci</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Farnesol, a common sesquiterpene, inhibits, P.Q.S production in <italic>Pseudomonas aeruginosa</italic></article-title>
<source/>Mol. Microbiol.
          <year>2007</year>
<volume>65</volume>
<fpage>896</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05840.x</pub-id>
<pub-id pub-id-type="pmid">17640272</pub-id>
</element-citation>
</ref>
<ref id="B110-microorganisms-07-00459">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Dolben</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Okegbe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Harty</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Golub</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Thao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ha</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Willger</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>O’Toole</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Harwood</surname>
<given-names>C.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Candida albicans</italic> ethanol stimulates <italic>Pseudomonas aeruginosa</italic> WspR-controlled biofilm formation as part of a cyclic relationship involving phenazines</article-title>
<source/>PloS Pathog.
          <year>2014</year>
<volume>10</volume>
<elocation-id>e1004480</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1004480</pub-id>
<pub-id pub-id-type="pmid">25340349</pub-id>
</element-citation>
</ref>
<ref id="B111-microorganisms-07-00459">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fourie</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pohl</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Beyond Antagonism: The Interaction Between <italic>Candida</italic> Species and <italic>Pseudomonas aeruginosa</italic></article-title>
<source/>J. Fungi (Basel)
          <year>2019</year>
<volume>5</volume>
<elocation-id>34</elocation-id>
<pub-id pub-id-type="doi">10.3390/jof5020034</pub-id>
<pub-id pub-id-type="pmid">31010211</pub-id>
</element-citation>
</ref>
<ref id="B112-microorganisms-07-00459">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavalcanti</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Del Bel Cury</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Nobbs</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Interactions between <italic>Streptococcus oralis</italic>, <italic>Actinomyces oris</italic>, and <italic>Candida albicans</italic> in the development of multispecies oral microbial biofilms on salivary pellicle</article-title>
<source/>Mol. Oral Microbiol.
          <year>2017</year>
<volume>32</volume>
<fpage>60</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1111/omi.12154</pub-id>
<pub-id pub-id-type="pmid">26834007</pub-id>
</element-citation>
</ref>
<ref id="B113-microorganisms-07-00459">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sobue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ricker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cervantes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>P.I.</given-names>
</name>
<name>
<surname>Dongari-Bagtzoglou</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Streptococcal co-infection augments <italic>Candida</italic> pathogenicity by amplifying the mucosal inflammatory response</article-title>
<source/>Cell Microbiol.
          <year>2014</year>
<volume>16</volume>
<fpage>214</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1111/cmi.12216</pub-id>
<pub-id pub-id-type="pmid">24079976</pub-id>
</element-citation>
</ref>
<ref id="B114-microorganisms-07-00459">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Gopal</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title>Adherence of <italic>Candida albicans</italic> to a cell surface polysaccharide receptor on <italic>Streptococcus gordonii</italic></article-title>
<source/>Infect. Immun.
          <year>1995</year>
<volume>63</volume>
<fpage>1827</fpage>
<lpage>1834</lpage>
<pub-id pub-id-type="pmid">7729891</pub-id>
</element-citation>
</ref>
<ref id="B115-microorganisms-07-00459">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>McNab</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> binding to the oral bacterium <italic>Streptococcus gordonii</italic> involves multiple adhesin-receptor interactions</article-title>
<source/>Infect. Immun.
          <year>1996</year>
<volume>64</volume>
<fpage>4680</fpage>
<lpage>4685</lpage>
<pub-id pub-id-type="pmid">8890225</pub-id>
</element-citation>
</ref>
<ref id="B116-microorganisms-07-00459">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nobbs</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Vickerman</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title>Heterologous expression of <italic>Candida albicans</italic> cell wall-associated adhesins in <italic>Saccharomyces cerevisiae</italic> Reveals differential specificities in adherence and biofilm formation and in binding oral <italic>Streptococcus gordonii</italic></article-title>
<source/>Eukaryot. Cell
          <year>2010</year>
<volume>9</volume>
<fpage>1622</fpage>
<lpage>1634</lpage>
<pub-id pub-id-type="doi">10.1128/EC.00103-10</pub-id>
<pub-id pub-id-type="pmid">20709785</pub-id>
</element-citation>
</ref>
<ref id="B117-microorganisms-07-00459">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Lala</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Shepherd</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Coaggregation of <italic>Streptococcus sanguis</italic> and other streptococci with <italic>Candida albicans</italic></article-title>
<source/>Infect. Immun.
          <year>1990</year>
<volume>58</volume>
<fpage>1429</fpage>
<lpage>1436</lpage>
<pub-id pub-id-type="pmid">2182544</pub-id>
</element-citation>
</ref>
<ref id="B118-microorganisms-07-00459">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Sullivan</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>R.D.</given-names>
</name>
</person-group>
<article-title>Adhesion of <italic>Candida albicans</italic> to oral streptococci is promoted by selective adsorption of salivary proteins to the streptococcal cell surface</article-title>
<source/>Microbiology
          <year>2000</year>
<volume>146</volume>
<fpage>41</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1099/00221287-146-1-41</pub-id>
<pub-id pub-id-type="pmid">10658650</pub-id>
</element-citation>
</ref>
<ref id="B119-microorganisms-07-00459">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sengupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Niepa</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Weljie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Freitas-Blanco</surname>
<given-names>V.S.</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Stebe</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> stimulates <italic>Streptococcus mutans</italic> microcolony development via cross-kingdom biofilm-derived metabolites</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>41332</fpage>
<pub-id pub-id-type="doi">10.1038/srep41332</pub-id>
<pub-id pub-id-type="pmid">28134351</pub-id>
</element-citation>
</ref>
<ref id="B120-microorganisms-07-00459">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montelongo-Jauregui</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Saville</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Lopez-Ribot</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Contributions of <italic>Candida albicans</italic> Dimorphism, Adhesive Interactions, and Extracellular Matrix to the Formation of Dual-Species Biofilms with <italic>Streptococcus gordonii</italic></article-title>
<source/>Mbio
          <year>2019</year>
<volume>10</volume>
<fpage>e01179-19</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.01179-19</pub-id>
<pub-id pub-id-type="pmid">31213561</pub-id>
</element-citation>
</ref>
<ref id="B121-microorganisms-07-00459">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>van der Wielen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cannon</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Ruske</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dawes</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> binds to saliva proteins selectively adsorbed to silicone</article-title>
<source/>Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
          <year>2006</year>
<volume>102</volume>
<fpage>488</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="doi">10.1016/j.tripleo.2005.10.052</pub-id>
<pub-id pub-id-type="pmid">16997116</pub-id>
</element-citation>
</ref>
<ref id="B122-microorganisms-07-00459">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bamford</surname>
<given-names>C.V.</given-names>
</name>
<name>
<surname>d’Mello</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nobbs</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Dutton</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Vickerman</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title><italic>Streptococcus gordonii</italic> modulates <italic>Candida albicans</italic> biofilm formation through intergeneric communication</article-title>
<source/>Infect. Immun.
          <year>2009</year>
<volume>77</volume>
<fpage>3696</fpage>
<lpage>3704</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00438-09</pub-id>
<pub-id pub-id-type="pmid">19528215</pub-id>
</element-citation>
</ref>
<ref id="B123-microorganisms-07-00459">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>W.N.</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>Q.K.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>A.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Streptococcus agalactiae</italic> Inhibits <italic>Candida albicans</italic> Hyphal Development and Diminishes Host Vaginal Mucosal, T.H.17 Response</article-title>
<source/>Front. Microbiol.
          <year>2018</year>
<volume>9</volume>
<fpage>198</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.00198</pub-id>
<pub-id pub-id-type="pmid">29527193</pub-id>
</element-citation>
</ref>
<ref id="B124-microorganisms-07-00459">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vilchez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lemme</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ballhausen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Thiel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sztajer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wagner-Döbler</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title><italic>Streptococcus mutans</italic> inhibits <italic>Candida albicans</italic> hyphal formation by the fatty acid signaling molecule trans-2-decenoic acid (SDSF)</article-title>
<source/>Chembiochem
          <year>2010</year>
<volume>11</volume>
<fpage>1552</fpage>
<lpage>1562</lpage>
<pub-id pub-id-type="doi">10.1002/cbic.201000086</pub-id>
<pub-id pub-id-type="pmid">20572249</pub-id>
</element-citation>
</ref>
<ref id="B125-microorganisms-07-00459">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarosz</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>van der Mei</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Crielaard</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Krom</surname>
<given-names>B.P.</given-names>
</name>
</person-group>
<article-title><italic>Streptococcus mutans</italic> competence-stimulating peptide inhibits <italic>Candida albicans</italic> hypha formation</article-title>
<source/>Eukaryot. Cell
          <year>2009</year>
<volume>8</volume>
<fpage>1658</fpage>
<lpage>1664</lpage>
<pub-id pub-id-type="doi">10.1128/EC.00070-09</pub-id>
<pub-id pub-id-type="pmid">19717744</pub-id>
</element-citation>
</ref>
<ref id="B126-microorganisms-07-00459">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahn</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z.T.</given-names>
</name>
<name>
<surname>Burne</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Multilevel control of competence development and stress tolerance in <italic>Streptococcus mutans</italic>, U.A.159</article-title>
<source/>Infect. Immun.
          <year>2006</year>
<volume>74</volume>
<fpage>1631</fpage>
<lpage>1642</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.74.3.1631-1642.2006</pub-id>
<pub-id pub-id-type="pmid">16495534</pub-id>
</element-citation>
</ref>
<ref id="B127-microorganisms-07-00459">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kucharikova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Van Dijck</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jabra-Rizk</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Commensal Protection of <italic>Staphylococcus aureus</italic> against Antimicrobials by <italic>Candida albicans</italic> Biofilm Matrix</article-title>
<source/>Mbio
          <year>2016</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.1128/mBio.01365-16</pub-id>
</element-citation>
</ref>
<ref id="B128-microorganisms-07-00459">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pate</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Wilhelmus</surname>
<given-names>K.R.</given-names>
</name>
</person-group>
<article-title>Prevalence and spectrum of bacterial co-infection during fungal keratitis</article-title>
<source/>Br. J. Ophthalmol.
          <year>2006</year>
<volume>90</volume>
<fpage>289</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.2005.081869</pub-id>
<pub-id pub-id-type="pmid">16488946</pub-id>
</element-citation>
</ref>
<ref id="B129-microorganisms-07-00459">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Narayan</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Interactions between bacteria and <italic>Candida</italic> in the burn wound</article-title>
<source/>Burns
          <year>2005</year>
<volume>31</volume>
<fpage>375</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1016/j.burns.2004.11.012</pub-id>
<pub-id pub-id-type="pmid">15774298</pub-id>
</element-citation>
</ref>
<ref id="B130-microorganisms-07-00459">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klotz</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Chasin</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gaur</surname>
<given-names>N.K.</given-names>
</name>
<name>
<surname>Lipke</surname>
<given-names>P.N.</given-names>
</name>
</person-group>
<article-title>Polymicrobial bloodstream infections involving <italic>Candida</italic> species: analysis of patients and review of the literature</article-title>
<source/>Diagn. Microbiol. Infect. Dis.
          <year>2007</year>
<volume>59</volume>
<fpage>401</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2007.07.001</pub-id>
<pub-id pub-id-type="pmid">17888612</pub-id>
</element-citation>
</ref>
<ref id="B131-microorganisms-07-00459">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlecht</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Krom</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Freiberg</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Hansch</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Filler</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Jabra-Rizk</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Shirtliff</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Systemic <italic>Staphylococcus aureus</italic> infection mediated by <italic>Candida albicans</italic> hyphal invasion of mucosal tissue</article-title>
<source/>Microbiology
          <year>2015</year>
<volume>161</volume>
<fpage>168</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1099/mic.0.083485-0</pub-id>
<pub-id pub-id-type="pmid">25332378</pub-id>
</element-citation>
</ref>
<ref id="B132-microorganisms-07-00459">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krause</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Geginat</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tammer</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Prostaglandin E2 from <italic>Candida albicans</italic> Stimulates the Growth of <italic>Staphylococcus aureus</italic> in Mixed Biofilms</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<elocation-id>e0135404</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0135404</pub-id>
<pub-id pub-id-type="pmid">26262843</pub-id>
</element-citation>
</ref>
<ref id="B133-microorganisms-07-00459">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shirtliff</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Jabra-Rizk</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Cross-kingdom interactions: <italic>Candida albicans</italic> and bacteria</article-title>
<source/>FEMS Microbiol. Lett.
          <year>2009</year>
<volume>299</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01668.x</pub-id>
<pub-id pub-id-type="pmid">19552706</pub-id>
</element-citation>
</ref>
<ref id="B134-microorganisms-07-00459">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname>
<given-names>E.F.</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kucharikova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Van Dijck</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jabra-Rizk</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Modulation of <italic>Staphylococcus aureus</italic> Response to Antimicrobials by the <italic>Candida albicans</italic> Quorum Sensing Molecule Farnesol</article-title>
<source/>Antimicrob. Agents Chemother.
          <year>2017</year>
<volume>61</volume>
<fpage>e01573-17</fpage>
<pub-id pub-id-type="doi">10.1128/AAC.01573-17</pub-id>
<pub-id pub-id-type="pmid">28893777</pub-id>
</element-citation>
</ref>
<ref id="B135-microorganisms-07-00459">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shiraishi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hirose</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hamashima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The antibacterial effects of terpene alcohols on <italic>Staphylococcus aureus</italic> and their mode of action</article-title>
<source/>FEMS Microbiol. Lett.
          <year>2004</year>
<volume>237</volume>
<fpage>325</fpage>
<lpage>331</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6968.2004.tb09714.x</pub-id>
<pub-id pub-id-type="pmid">15321680</pub-id>
</element-citation>
</ref>
<ref id="B136-microorganisms-07-00459">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jabra-Rizk</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Meiller</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Shirtliff</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Effect of farnesol on <italic>Staphylococcus aureus</italic> biofilm formation and antimicrobial susceptibility</article-title>
<source/>Antimicrob. Agents Chemother.
          <year>2006</year>
<volume>50</volume>
<fpage>1463</fpage>
<lpage>1469</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.50.4.1463-1469.2006</pub-id>
<pub-id pub-id-type="pmid">16569866</pub-id>
</element-citation>
</ref>
<ref id="B137-microorganisms-07-00459">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camarillo-Marquez</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Cordova-Alcantara</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Hernandez-Rodriguez</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Garcia-Perez</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Martinez-Rivera</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Rodríguez-Tovar</surname>
<given-names>A.V.</given-names>
</name>
</person-group>
<article-title>Antagonistic Interaction of <italic>Staphylococcus aureus</italic> Toward <italic>Candida glabrata</italic> During in vitro Biofilm Formation Is Caused by an Apoptotic Mechanism</article-title>
<source/>Front. Microbiol.
          <year>2018</year>
<volume>9</volume>
<fpage>2031</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.02031</pub-id>
<pub-id pub-id-type="pmid">30214437</pub-id>
</element-citation>
</ref>
<ref id="B138-microorganisms-07-00459">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garsin</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> and <italic>Enterococcus faecalis</italic> in the gut: synergy in commensalism?</article-title>
<source/>Gut Microbes
          <year>2013</year>
<volume>4</volume>
<fpage>409</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="doi">10.4161/gmic.26040</pub-id>
<pub-id pub-id-type="pmid">23941906</pub-id>
</element-citation>
</ref>
<ref id="B139-microorganisms-07-00459">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovac</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kovac</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Slobodnikova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kotulova</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title><italic>Enterococcus faecalis</italic> and <italic>Candida albicans</italic> in the dental root canal and periapical infections</article-title>
<source/>Bratisl. Lek. Listy.
          <year>2013</year>
<volume>114</volume>
<fpage>716</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="pmid">24329511</pub-id>
</element-citation>
</ref>
<ref id="B140-microorganisms-07-00459">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cruz</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Gagliano</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Garsin</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title><italic>Enterococcus faecalis</italic> inhibits hyphal morphogenesis and virulence of <italic>Candida albicans</italic></article-title>
<source/>Infect. Immun.
          <year>2013</year>
<volume>81</volume>
<fpage>189</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00914-12</pub-id>
<pub-id pub-id-type="pmid">23115035</pub-id>
</element-citation>
</ref>
<ref id="B141-microorganisms-07-00459">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Garsin</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title><italic>Enterococcus faecalis</italic> bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of <italic>Candida albicans</italic></article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2017</year>
<volume>114</volume>
<fpage>4507</fpage>
<lpage>4512</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1620432114</pub-id>
<pub-id pub-id-type="pmid">28396417</pub-id>
</element-citation>
</ref>
<ref id="B142-microorganisms-07-00459">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shekh</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Biochemical characterization of an anti-<italic>Candida</italic> factor produced by <italic>Enterococcus faecalis</italic></article-title>
<source/>BMC Microbiol.
          <year>2012</year>
<volume>12</volume>
<fpage>1471</fpage>
<lpage>2180</lpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-12-132</pub-id>
<pub-id pub-id-type="pmid">22759735</pub-id>
</element-citation>
</ref>
<ref id="B143-microorganisms-07-00459">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutton</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Lamont</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Nobbs</surname>
<given-names>A.H.</given-names>
</name>
</person-group>
<article-title>Role of <italic>Candida albicans</italic> secreted aspartyl protease Sap9 in interkingdom biofilm formation</article-title>
<source/>Pathog. Dis.
          <year>2016</year>
<volume>74</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1093/femspd/ftw005</pub-id>
<pub-id pub-id-type="pmid">26772652</pub-id>
</element-citation>
</ref>
<ref id="B144-microorganisms-07-00459">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boris</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Barbes</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Role played by lactobacilli in controlling the population of vaginal pathogens</article-title>
<source/>Microbes Infect.
          <year>2000</year>
<volume>2</volume>
<fpage>543</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.1016/S1286-4579(00)00313-0</pub-id>
<pub-id pub-id-type="pmid">10865199</pub-id>
</element-citation>
</ref>
<ref id="B145-microorganisms-07-00459">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noverr</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Huffnagle</surname>
<given-names>G.B.</given-names>
</name>
</person-group>
<article-title>Regulation of <italic>Candida albicans</italic> morphogenesis by fatty acid metabolites</article-title>
<source/>Infect. Immun.
          <year>2004</year>
<volume>72</volume>
<fpage>6206</fpage>
<lpage>6210</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.72.11.6206-6210.2004</pub-id>
<pub-id pub-id-type="pmid">15501745</pub-id>
</element-citation>
</ref>
<ref id="B146-microorganisms-07-00459">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vylkova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carman</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Danhof</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Collette</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>The fungal pathogen <italic>Candida albicans</italic> autoinduces hyphal morphogenesis by raising extracellular pH</article-title>
<source/>Mbio
          <year>2011</year>
<volume>2</volume>
<fpage>e00055-11</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.00055-11</pub-id>
<pub-id pub-id-type="pmid">21586647</pub-id>
</element-citation>
</ref>
<ref id="B147-microorganisms-07-00459">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Antimicrobial Compounds Produced by Vaginal <italic>Lactobacillus crispatus</italic> Are Able to Strongly Inhibit <italic>Candida albicans</italic> Growth, Hyphal Formation and Regulate Virulence-related Gene Expressions</article-title>
<source/>Front. Microbiol.
          <year>2017</year>
<volume>8</volume>
<fpage>564</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.00564</pub-id>
<pub-id pub-id-type="pmid">28421058</pub-id>
</element-citation>
</ref>
<ref id="B148-microorganisms-07-00459">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimaudo</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Nesbitt</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>W.B.</given-names>
</name>
</person-group>
<article-title>Coaggregation of <italic>Candida albicans</italic> with oral Actinomyces species</article-title>
<source/>Oral Microbiol. Immunol.
          <year>1996</year>
<volume>11</volume>
<fpage>59</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-302X.1996.tb00337.x</pub-id>
<pub-id pub-id-type="pmid">8604256</pub-id>
</element-citation>
</ref>
<ref id="B149-microorganisms-07-00459">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arzmi</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Dashper</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Catmull</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cirillo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>McCullough</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Coaggregation of <italic>Candida albicans</italic>, <italic>Actinomyces naeslundii</italic> and <italic>Streptococcus mutans</italic> is <italic>Candida albicans</italic> strain dependent</article-title>
<source/>FEMS Yeast Res.
          <year>2015</year>
<volume>15</volume>
<fpage>7</fpage>
<pub-id pub-id-type="doi">10.1093/femsyr/fov038</pub-id>
</element-citation>
</ref>
<ref id="B150-microorganisms-07-00459">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arzmi</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Alnuaimi</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Dashper</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cirillo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>McCullough</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Polymicrobial biofilm formation by <italic>Candida albicans</italic>, <italic>Actinomyces naeslundii</italic>, and <italic>Streptococcus mutans</italic> is <italic>Candida albicans</italic> strain and medium dependent</article-title>
<source/>Med. Mycol.
          <year>2016</year>
<volume>54</volume>
<fpage>856</fpage>
<lpage>864</lpage>
<pub-id pub-id-type="doi">10.1093/mmy/myw042</pub-id>
<pub-id pub-id-type="pmid">27354487</pub-id>
</element-citation>
</ref>
<ref id="B151-microorganisms-07-00459">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Cross-kingdom interaction of <italic>Candida albicans</italic> and <italic>Actinomyces viscosus</italic> elevated cariogenic virulence</article-title>
<source/>Arch. Oral Biol.
          <year>2019</year>
<volume>100</volume>
<fpage>106</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1016/j.archoralbio.2019.02.008</pub-id>
<pub-id pub-id-type="pmid">30822704</pub-id>
</element-citation>
</ref>
<ref id="B152-microorganisms-07-00459">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peleg</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Seifert</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title><italic>Acinetobacter baumannii</italic>: emergence of a successful pathogen</article-title>
<source/>Clin. Microbiol. Rev.
          <year>2008</year>
<volume>21</volume>
<fpage>538</fpage>
<lpage>582</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.00058-07</pub-id>
<pub-id pub-id-type="pmid">18625687</pub-id>
</element-citation>
</ref>
<ref id="B153-microorganisms-07-00459">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peleg</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Tampakakis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Eliopoulos</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Moellering</surname>
<given-names>R.C.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Mylonakis</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Prokaryote-eukaryote interactions identified by using <italic>Caenorhabditis elegans</italic></article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>14585</fpage>
<lpage>14590</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0805048105</pub-id>
<pub-id pub-id-type="pmid">18794525</pub-id>
</element-citation>
</ref>
<ref id="B154-microorganisms-07-00459">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaddy</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Tomaras</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Actis</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>The <italic>Acinetobacter baumannii</italic> 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells</article-title>
<source/>Infect. Immun.
          <year>2009</year>
<volume>77</volume>
<fpage>3150</fpage>
<lpage>3160</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.00096-09</pub-id>
<pub-id pub-id-type="pmid">19470746</pub-id>
</element-citation>
</ref>
<ref id="B155-microorganisms-07-00459">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostoulias</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Cerqueira</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Bantun</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mylonakis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Khoo</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Peleg</surname>
<given-names>A.Y.</given-names>
</name>
</person-group>
<article-title>Impact of a Cross-Kingdom Signaling Molecule of <italic>Candida albicans</italic> on <italic>Acinetobacter baumannii</italic> Physiology</article-title>
<source/>Antimicrob. Agents Chemother.
          <year>2015</year>
<volume>60</volume>
<fpage>161</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.01540-15</pub-id>
<pub-id pub-id-type="pmid">26482299</pub-id>
</element-citation>
</ref>
<ref id="B156-microorganisms-07-00459">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006</article-title>
<source/>J. Microbiol. Immunol. Infect.
          <year>2010</year>
<volume>43</volume>
<fpage>416</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1016/S1684-1182(10)60065-5</pub-id>
<pub-id pub-id-type="pmid">21075709</pub-id>
</element-citation>
</ref>
<ref id="B157-microorganisms-07-00459">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachtiar</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Bachtiar</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Jarosz</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Amir</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Sunarto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ganin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meijler</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Krom</surname>
<given-names>B.P.</given-names>
</name>
</person-group>
<article-title>AI-2 of <italic>Aggregatibacter actinomycetemcomitans</italic> inhibits <italic>Candida albicans</italic> biofilm formation</article-title>
<source/>Front. Cell Infect. Microbiol.
          <year>2014</year>
<volume>4</volume>
<fpage>94</fpage>
<pub-id pub-id-type="doi">10.3389/fcimb.2014.00094</pub-id>
<pub-id pub-id-type="pmid">25101248</pub-id>
</element-citation>
</ref>
<ref id="B158-microorganisms-07-00459">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brusca</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Rosa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Albaina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Moragues</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Verdugo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pontón</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The impact of oral contraceptives on women’s periodontal health and the subgingival occurrence of aggressive periodontopathogens and <italic>Candida</italic> species</article-title>
<source/>J. Periodontol.
          <year>2010</year>
<volume>81</volume>
<fpage>1010</fpage>
<lpage>1018</lpage>
<pub-id pub-id-type="doi">10.1902/jop.2010.090575</pub-id>
<pub-id pub-id-type="pmid">20370418</pub-id>
</element-citation>
</ref>
<ref id="B159-microorganisms-07-00459">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rickard</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Campagna</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Kolenbrander</surname>
<given-names>P.E.</given-names>
</name>
</person-group>
<article-title>Autoinducer-2 is produced in saliva-fed flow conditions relevant to natural oral biofilms</article-title>
<source/>J. Appl. Microbiol.
          <year>2008</year>
<volume>105</volume>
<fpage>2096</fpage>
<lpage>2103</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2672.2008.03910.x</pub-id>
<pub-id pub-id-type="pmid">19120655</pub-id>
</element-citation>
</ref>
<ref id="B160-microorganisms-07-00459">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlson</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice</article-title>
<source/>Infect. Immun.
          <year>1983</year>
<volume>39</volume>
<fpage>193</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="pmid">6401691</pub-id>
</element-citation>
</ref>
<ref id="B161-microorganisms-07-00459">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Silverwood</surname>
<given-names>R.W.</given-names>
</name>
</person-group>
<article-title>Coagglutination reactions between <italic>Candida albicans</italic> and oral bacteria</article-title>
<source/>J. Med. Microbiol.
          <year>1986</year>
<volume>22</volume>
<fpage>165</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1099/00222615-22-2-165</pub-id>
<pub-id pub-id-type="pmid">3018251</pub-id>
</element-citation>
</ref>
<ref id="B162-microorganisms-07-00459">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimaudo</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Nesbitt</surname>
<given-names>W.E.</given-names>
</name>
</person-group>
<article-title>Coaggregation of <italic>Candida albicans</italic> with oral <italic>Fusobacterium</italic> species</article-title>
<source/>Oral Microbiol. Immunol.
          <year>1997</year>
<volume>12</volume>
<fpage>168</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-302X.1997.tb00374.x</pub-id>
<pub-id pub-id-type="pmid">9467403</pub-id>
</element-citation>
</ref>
<ref id="B163-microorganisms-07-00459">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jabra-Rizk</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Falkler</surname>
<given-names>W.A.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Merz</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Baqui</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Meiller</surname>
<given-names>T.F.</given-names>
</name>
</person-group>
<article-title>Coaggregation of <italic>Candida dubliniensis</italic> with <italic>Fusobacterium nucleatum</italic></article-title>
<source/>J. Clin. Microbiol.
          <year>1999</year>
<volume>37</volume>
<fpage>1464</fpage>
<lpage>1468</lpage>
<pub-id pub-id-type="pmid">10203506</pub-id>
</element-citation>
</ref>
<ref id="B164-microorganisms-07-00459">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bor</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Agnello</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Morphological and physiological changes induced by contact-dependent interaction between <italic>Candida albicans</italic> and <italic>Fusobacterium nucleatum</italic></article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>27956</fpage>
<pub-id pub-id-type="doi">10.1038/srep27956</pub-id>
<pub-id pub-id-type="pmid">27295972</pub-id>
</element-citation>
</ref>
<ref id="B165-microorganisms-07-00459">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lux</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Cellular Components Mediating Coadherence of <italic>Candida albicans</italic> and <italic>Fusobacterium nucleatum</italic></article-title>
<source/>J. Dent. Res.
          <year>2015</year>
<volume>94</volume>
<fpage>1432</fpage>
<lpage>1438</lpage>
<pub-id pub-id-type="doi">10.1177/0022034515593706</pub-id>
<pub-id pub-id-type="pmid">26152186</pub-id>
</element-citation>
</ref>
<ref id="B166-microorganisms-07-00459">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldwin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahenthiralingam</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Drevinek</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vandamme</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Govan</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Waine</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>LiPuma</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Chiarini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dalmastri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>D.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Environmental <italic>Burkholderia cepacia</italic> complex isolates in human infections</article-title>
<source/>Emerg. Infect. Dis.
          <year>2007</year>
<volume>13</volume>
<fpage>458</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.3201/eid1303.060403</pub-id>
<pub-id pub-id-type="pmid">17552100</pub-id>
</element-citation>
</ref>
<ref id="B167-microorganisms-07-00459">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sousa</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Leitao</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants</article-title>
<source/>Int. J. Microbiol.
          <year>2011</year>
<volume>10</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1155/2011/607575</pub-id>
</element-citation>
</ref>
<ref id="B168-microorganisms-07-00459">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>S.Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>A novel, D.S.F-like signal from <italic>Burkholderia cenocepacia</italic> interferes with <italic>Candida albicans</italic> morphological transition</article-title>
<source/>ISME J.
          <year>2008</year>
<volume>2</volume>
<fpage>27</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1038/ismej.2007.76</pub-id>
<pub-id pub-id-type="pmid">18049456</pub-id>
</element-citation>
</ref>
<ref id="B169-microorganisms-07-00459">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>L.X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>BDSF inhibits <italic>Candida albicans</italic> adherence to urinary catheters</article-title>
<source/>Microb. Pathog.
          <year>2013</year>
<volume>64</volume>
<fpage>33</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1016/j.micpath.2013.07.003</pub-id>
<pub-id pub-id-type="pmid">23948468</pub-id>
</element-citation>
</ref>
<ref id="B170-microorganisms-07-00459">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fox</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Cowley</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Nobile</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Hartooni</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Anaerobic bacteria grow within <italic>Candida albicans</italic> biofilms and induce biofilm formation in suspension cultures</article-title>
<source/>Curr. Biol.
          <year>2014</year>
<volume>24</volume>
<fpage>2411</fpage>
<lpage>2416</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2014.08.057</pub-id>
<pub-id pub-id-type="pmid">25308076</pub-id>
</element-citation>
</ref>
<ref id="B171-microorganisms-07-00459">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Leeuwen</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>van der Peet</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Bikker</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Hoogenkamp</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Oliveira Paiva</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Kostidis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mayboroda</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Smits</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Krom</surname>
<given-names>B.P.</given-names>
</name>
</person-group>
<article-title>Interspecies Interactions between <italic>Clostridium difficile</italic> and <italic>Candida albicans</italic></article-title>
<source/>Msphere
          <year>2016</year>
<volume>1</volume>
<fpage>e00187-16</fpage>
<pub-id pub-id-type="doi">10.1128/mSphere.00187-16</pub-id>
<pub-id pub-id-type="pmid">27840850</pub-id>
</element-citation>
</ref>
<ref id="B172-microorganisms-07-00459">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somerville</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Proctor</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Cultivation conditions and the diffusion of oxygen into culture media: the rationale for the flask-to-medium ratio in microbiology</article-title>
<source/>BMC Microbiol.
          <year>2013</year>
<volume>13</volume>
<fpage>1471</fpage>
<lpage>2180</lpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-13-9</pub-id>
<pub-id pub-id-type="pmid">23324109</pub-id>
</element-citation>
</ref>
<ref id="B173-microorganisms-07-00459">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dione</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Khelaifia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lagier</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Raoult</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The aerobic activity of metronidazole against anaerobic bacteria</article-title>
<source/>Int. J. Antimicrob. Agents
          <year>2015</year>
<volume>45</volume>
<fpage>537</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2014.12.032</pub-id>
<pub-id pub-id-type="pmid">25813393</pub-id>
</element-citation>
</ref>
<ref id="B174-microorganisms-07-00459">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janus</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Crielaard</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Volgenant</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>van der Veen</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Krom</surname>
<given-names>B.P.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> alters the bacterial microbiome of early in vitro oral biofilms</article-title>
<source/>J. Oral. Microbiol.
          <year>2017</year>
<volume>9</volume>
<fpage>1270613</fpage>
<pub-id pub-id-type="doi">10.1080/20002297.2016.1270613</pub-id>
<pub-id pub-id-type="pmid">28326152</pub-id>
</element-citation>
</ref>
<ref id="B175-microorganisms-07-00459">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tampakakis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Peleg</surname>
<given-names>A.Y.</given-names>
</name>
<name>
<surname>Mylonakis</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Interaction of <italic>Candida albicans</italic> with an intestinal pathogen, <italic>Salmonella enterica</italic> serovar <italic>Typhimurium</italic></article-title>
<source/>Eukaryot. Cell.
          <year>2009</year>
<volume>8</volume>
<fpage>732</fpage>
<lpage>737</lpage>
<pub-id pub-id-type="doi">10.1128/EC.00016-09</pub-id>
<pub-id pub-id-type="pmid">19329669</pub-id>
</element-citation>
</ref>
<ref id="B176-microorganisms-07-00459">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mylonakis</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Killing of <italic>Candida albicans</italic> filaments by <italic>Salmonella enterica</italic> serovar <italic>Typhimurium</italic> is mediated by sopB effectors, parts of a type, I.I.I secretion system</article-title>
<source/>Eukaryot. Cell.
          <year>2011</year>
<volume>10</volume>
<fpage>782</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1128/EC.00014-11</pub-id>
<pub-id pub-id-type="pmid">21498643</pub-id>
</element-citation>
</ref>
<ref id="B177-microorganisms-07-00459">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mislin</surname>
<given-names>G.L.A.</given-names>
</name>
<name>
<surname>Latge</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Beauvais</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Interactions between <italic>Aspergillus fumigatus</italic> and Pulmonary Bacteria: Current State of the Field, New Data, and Future Perspective</article-title>
<source/>J. Fungi (Basel)
          <year>2019</year>
<volume>5</volume>
<elocation-id>48</elocation-id>
<pub-id pub-id-type="doi">10.3390/jof5020048</pub-id>
</element-citation>
</ref>
<ref id="B178-microorganisms-07-00459">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sass</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nazik</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Penner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ansari</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Clemons</surname>
<given-names>K.V.</given-names>
</name>
<name>
<surname>Groleau</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Dietl</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Visca</surname>
</name>
<name>
<surname>Haas</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Aspergillus-Pseudomonas</italic> interaction, relevant to competition in airways</article-title>
<source/>Med Mycol
          <year>2019</year>
<volume>57</volume>
<fpage>S228</fpage>
<lpage>S232</lpage>
<pub-id pub-id-type="doi">10.1093/mmy/myy087</pub-id>
<pub-id pub-id-type="pmid">30816973</pub-id>
</element-citation>
</ref>
<ref id="B179-microorganisms-07-00459">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sass</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nazik</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Penner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ansari</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Clemons</surname>
<given-names>K.V.</given-names>
</name>
<name>
<surname>Groleau</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Dietl</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Visca</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Studies of <italic>Pseudomonas aeruginosa</italic> Mutants Indicate Pyoverdine as the Central Factor in Inhibition of <italic>Aspergillus fumigatus</italic> Biofilm</article-title>
<source/>J. Bacteriol.
          <year>2017</year>
<volume>200</volume>
<fpage>e00345-17</fpage>
<pub-id pub-id-type="doi">10.1128/JB.00345-17</pub-id>
<pub-id pub-id-type="pmid">29038255</pub-id>
</element-citation>
</ref>
<ref id="B180-microorganisms-07-00459">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reece</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Greally</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Renwick</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McClean</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title><italic>Aspergillus fumigatus</italic> Inhibits <italic>Pseudomonas aeruginosa</italic> in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the, C.F. Airway</article-title>
<source/>Front. Microbiol.
          <year>2018</year>
<volume>9</volume>
<fpage>1205</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.01205</pub-id>
<pub-id pub-id-type="pmid">29922270</pub-id>
</element-citation>
</ref>
<ref id="B181-microorganisms-07-00459">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mowat</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rajendran</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>McCulloch</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title><italic>Pseudomonas aeruginosa</italic> and their small diffusible extracellular molecules inhibit <italic>Aspergillus fumigatus</italic> biofilm formation</article-title>
<source/>FEMS Microbiol. Lett.
          <year>2010</year>
<volume>313</volume>
<fpage>96</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1111/j.1574-6968.2010.02130.x</pub-id>
<pub-id pub-id-type="pmid">20964704</pub-id>
</element-citation>
</ref>
<ref id="B182-microorganisms-07-00459">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferreira</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Penner</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>R.B.</given-names>
</name>
<name>
<surname>Haagensen</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Clemons</surname>
<given-names>K.V.</given-names>
</name>
<name>
<surname>Spormann</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Nazik</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Banaei</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Carolino</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inhibition of <italic>Aspergillus fumigatus</italic> and Its Biofilm by <italic>Pseudomonas aeruginosa</italic> Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium</article-title>
<source/>PLoS ONE
          <year>2015</year>
<volume>10</volume>
<elocation-id>e0134692</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0134692</pub-id>
<pub-id pub-id-type="pmid">26252384</pub-id>
</element-citation>
</ref>
<ref id="B183-microorganisms-07-00459">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sass</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ansari</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Dietl</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Deziel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Intermicrobial interaction: <italic>Aspergillus fumigatus</italic> siderophores protect against competition by <italic>Pseudomonas aeruginosa</italic></article-title>
<source/>PLoS ONE
          <year>2019</year>
<volume>14</volume>
<elocation-id>e0216085</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0216085</pub-id>
<pub-id pub-id-type="pmid">31067259</pub-id>
</element-citation>
</ref>
<ref id="B184-microorganisms-07-00459">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Heddergott</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Latge</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Volatile Compounds Emitted by <italic>Pseudomonas aeruginosa</italic> Stimulate Growth of the Fungal Pathogen <italic>Aspergillus fumigatus</italic></article-title>
<source/>Mbio
          <year>2016</year>
<volume>7</volume>
<fpage>e00219</fpage>
<pub-id pub-id-type="doi">10.1128/mBio.00219-16</pub-id>
<pub-id pub-id-type="pmid">26980832</pub-id>
</element-citation>
</ref>
<ref id="B185-microorganisms-07-00459">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nutzmann</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Reyes-Dominguez</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Scherlach</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schroeckh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Horn</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gacek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schümann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hertweck</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brakhage</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Bacteria-induced natural product formation in the fungus <italic>Aspergillus nidulans</italic> requires Saga/Ada-mediated histone acetylation</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<fpage>14282</fpage>
<lpage>14287</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1103523108</pub-id>
<pub-id pub-id-type="pmid">21825172</pub-id>
</element-citation>
</ref>
<ref id="B186-microorganisms-07-00459">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroeckh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Scherlach</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nutzmann</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Shelest</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schmidt-Heck</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schuemann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hertweck</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brakhage</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in <italic>Aspergillus nidulans</italic></article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>14558</fpage>
<lpage>14563</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0901870106</pub-id>
<pub-id pub-id-type="pmid">19666480</pub-id>
</element-citation>
</ref>
<ref id="B187-microorganisms-07-00459">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Netzker</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jager</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gacek-Matthews</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scherlach</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stroe</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>García-Altares</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pezzini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Schoeler</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chromatin mapping identifies BasR, a key regulator of bacteria-triggered production of fungal secondary metabolites</article-title>
<source/>Elife
          <year>2018</year>
<volume>12</volume>
<fpage>40969</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.40969</pub-id>
</element-citation>
</ref>
<ref id="B188-microorganisms-07-00459">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandl</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>M.Q.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title><italic>Salmonella</italic> biofilm formation on <italic>Aspergillus niger</italic> involves cellulose--chitin interactions</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<elocation-id>e25553</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0025553</pub-id>
<pub-id pub-id-type="pmid">22003399</pub-id>
</element-citation>
</ref>
<ref id="B189-microorganisms-07-00459">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogueira</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jenull</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kuchler</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lion</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title><italic>Klebsiella pneumoniae</italic> prevents spore germination and hyphal development of <italic>Aspergillus</italic> species</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<fpage>018</fpage>
<lpage>36524</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-36524-8</pub-id>
</element-citation>
</ref>
<ref id="B190-microorganisms-07-00459">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Montagna</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Luberto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Del Poeta</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title><italic>Pseudomonas aeruginosa</italic> inhibits the growth of <italic>Cryptococcus</italic> species</article-title>
<source/>Mycopathologia
          <year>2012</year>
<volume>173</volume>
<fpage>451</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-011-9494-7</pub-id>
<pub-id pub-id-type="pmid">22076410</pub-id>
</element-citation>
</ref>
<ref id="B191-microorganisms-07-00459">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teoh-Chan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chau</surname>
<given-names>P.Y.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>P.C.</given-names>
</name>
</person-group>
<article-title>Inhibition of Cryptococcus neoformans by Pseudomonas aeruginosa</article-title>
<source/>J. Med. Microbiol.
          <year>1975</year>
<volume>8</volume>
<fpage>77</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1099/00222615-8-1-77</pub-id>
<pub-id pub-id-type="pmid">805243</pub-id>
</element-citation>
</ref>
<ref id="B192-microorganisms-07-00459">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frases</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chaskes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dadachova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Casadevall</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Induction by <italic>Klebsiella aerogenes</italic> of a melanin-like pigment in <italic>Cryptococcus neoformans</italic></article-title>
<source/>Appl. Env. Microbiol.
          <year>2006</year>
<volume>72</volume>
<fpage>1542</fpage>
<lpage>1550</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.72.2.1542-1550.2006</pub-id>
<pub-id pub-id-type="pmid">16461709</pub-id>
</element-citation>
</ref>
<ref id="B193-microorganisms-07-00459">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frases</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Salazar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dadachova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Casadevall</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title><italic>Cryptococcus neoformans</italic> can utilize the bacterial melanin precursor homogentisic acid for fungal melanogenesis</article-title>
<source/>Appl. Env. Microbiol.
          <year>2007</year>
<volume>73</volume>
<fpage>615</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.01947-06</pub-id>
<pub-id pub-id-type="pmid">17098915</pub-id>
</element-citation>
</ref>
<ref id="B194-microorganisms-07-00459">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rick</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Woolnough</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pashley</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Wardlaw</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Allergic Fungal Airway Disease</article-title>
<source/>J. Investig. Allergol. Clin. Immunol.
          <year>2016</year>
<volume>26</volume>
<fpage>344</fpage>
<lpage>354</lpage>
<pub-id pub-id-type="doi">10.18176/jiaci.0122</pub-id>
<pub-id pub-id-type="pmid">27996940</pub-id>
</element-citation>
</ref>
<ref id="B195-microorganisms-07-00459">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Synthetic multispecies microbial communities reveals shifts in secondary metabolism and facilitates cryptic natural product discovery</article-title>
<source/>Env. Microbiol.
          <year>2017</year>
<volume>19</volume>
<fpage>3606</fpage>
<lpage>3618</lpage>
<pub-id pub-id-type="doi">10.1111/1462-2920.13858</pub-id>
<pub-id pub-id-type="pmid">28714207</pub-id>
</element-citation>
</ref>
<ref id="B196-microorganisms-07-00459">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butt</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Iron Acquisition Mechanisms and Their Role in the Virulence of <italic>Burkholderia</italic> Species</article-title>
<source/>Front. Cell Infect. Microbiol.
          <year>2017</year>
<volume>7</volume>
<fpage>460</fpage>
<pub-id pub-id-type="doi">10.3389/fcimb.2017.00460</pub-id>
<pub-id pub-id-type="pmid">29164069</pub-id>
</element-citation>
</ref>
<ref id="B197-microorganisms-07-00459">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Opel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Scherlach</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hertweck</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Biosynthesis of antifungal and antibacterial polyketides by <italic>Burkholderia gladioli</italic> in coculture with <italic>Rhizopus microsporus</italic></article-title>
<source/>Mycoses
          <year>2014</year>
<volume>3</volume>
<fpage>48</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1111/myc.12246</pub-id>
</element-citation>
</ref>
<ref id="B198-microorganisms-07-00459">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moebius</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Scherlach</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rohm</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Roth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hertweck</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Biosynthesis of the respiratory toxin bongkrekic acid in the pathogenic bacterium <italic>Burkholderia gladioli</italic></article-title>
<source/>Chem. Biol.
          <year>2012</year>
<volume>19</volume>
<fpage>1164</fpage>
<lpage>1174</lpage>
<pub-id pub-id-type="doi">10.1016/j.chembiol.2012.07.022</pub-id>
<pub-id pub-id-type="pmid">22999884</pub-id>
</element-citation>
</ref>
<ref id="B199-microorganisms-07-00459">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lackner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Moebius</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Partida-Martinez</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Boland</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hertweck</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Evolution of an endofungal lifestyle: Deductions from the <italic>Burkholderia rhizoxinica</italic> genome</article-title>
<source/>BMC Genomics
          <year>2011</year>
<volume>12</volume>
<fpage>1471</fpage>
<lpage>2164</lpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-12-210</pub-id>
</element-citation>
</ref>
<ref id="B200-microorganisms-07-00459">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Des Etages</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Microbial synergy via an ethanol-triggered pathway</article-title>
<source/>Mol. Cell Biol.
          <year>2004</year>
<volume>24</volume>
<fpage>3874</fpage>
<lpage>3884</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.24.9.3874-3884.2004</pub-id>
<pub-id pub-id-type="pmid">15082781</pub-id>
</element-citation>
</ref>
<ref id="B201-microorganisms-07-00459">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gandhi</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Ekhar</surname>
<given-names>V.V.</given-names>
</name>
<name>
<surname>Asplund</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Abdulkareem</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Coelho</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>L.R.</given-names>
</name>
</person-group>
<article-title>Alcohol enhances <italic>Acinetobacter baumannii</italic>-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e95707</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0095707</pub-id>
<pub-id pub-id-type="pmid">24752133</pub-id>
</element-citation>
</ref>
<ref id="B202-microorganisms-07-00459">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaur</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pethani</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sunna</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kautto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Penesyan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>I.T.</given-names>
</name>
<name>
<surname>Nevalainen</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title><italic>Pseudomonas aeruginosa</italic> inhibits the growth of <italic>Scedosporium aurantiacum</italic>, an opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients</article-title>
<source/>Front. Microbiol.
          <year>2015</year>
<volume>6</volume>
<fpage>866</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.00866</pub-id>
<pub-id pub-id-type="pmid">26379643</pub-id>
</element-citation>
</ref>
<ref id="B203-microorganisms-07-00459">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Byth</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Middleton</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Nevalainen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sorrell</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title><italic>Pseudomonas aeruginosa</italic> Inhibits the Growth of <italic>Scedosporium</italic> and <italic>Lomentospora In Vitro</italic></article-title>
<source/>Mycopathologia
          <year>2018</year>
<volume>183</volume>
<fpage>251</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1007/s11046-017-0140-x</pub-id>
<pub-id pub-id-type="pmid">28512704</pub-id>
</element-citation>
</ref>
<ref id="B204-microorganisms-07-00459">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappas</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Lionakis</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Arendrup</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Ostrosky-Zeichner</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kullberg</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Invasive candidiasis</article-title>
<source/>Nat. Rev. Dis. Primers
          <year>2018</year>
<volume>4</volume>
<fpage>18026</fpage>
<pub-id pub-id-type="doi">10.1038/nrdp.2018.26</pub-id>
<pub-id pub-id-type="pmid">29749387</pub-id>
</element-citation>
</ref>
<ref id="B205-microorganisms-07-00459">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chin</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>T.Y.</given-names>
</name>
<name>
<surname>Rusliza</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>P.P.</given-names>
</name>
</person-group>
<article-title>Dissecting <italic>Candida albicans</italic> Infection from the Perspective of <italic>C. albicans</italic> Virulence and Omics Approaches on Host-Pathogen Interaction: A Review</article-title>
<source/>Int. J. Mol. Sci.
          <year>2016</year>
<volume>17</volume>
<elocation-id>1643</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms17101643</pub-id>
</element-citation>
</ref>
<ref id="B206-microorganisms-07-00459">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patin</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Orr</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Pattern recognition receptors in fungal immunity</article-title>
<source/>Semin. Cell Dev. Biol.
          <year>2018</year>
<volume>8</volume>
<fpage>30541</fpage>
<lpage>30544</lpage>
<pub-id pub-id-type="doi">10.1016/j.semcdb.2018.03.003</pub-id>
</element-citation>
</ref>
<ref id="B207-microorganisms-07-00459">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Espinosa</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Cytokines and the regulation of fungus-specific, C.D.4 T cell differentiation</article-title>
<source/>Cytokine
          <year>2012</year>
<volume>58</volume>
<fpage>100</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2011.11.005</pub-id>
<pub-id pub-id-type="pmid">22133343</pub-id>
</element-citation>
</ref>
<ref id="B208-microorganisms-07-00459">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pichard</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Cowen</surname>
<given-names>E.W.</given-names>
</name>
</person-group>
<article-title>Primary immunodeficiency update: Part, I.I.. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestations</article-title>
<source/>J. Am. Acad. Dermatol.
          <year>2015</year>
<volume>73</volume>
<fpage>367</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaad.2015.01.055</pub-id>
<pub-id pub-id-type="pmid">26282795</pub-id>
</element-citation>
</ref>
<ref id="B209-microorganisms-07-00459">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaplin</surname>
<given-names>D.D.</given-names>
</name>
</person-group>
<article-title>Overview of the immune response</article-title>
<source/>J. Allergy Clin. Immunol.
          <year>2010</year>
<volume>125</volume>
<fpage>980</fpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2009.12.980</pub-id>
<pub-id pub-id-type="pmid">20304475</pub-id>
</element-citation>
</ref>
<ref id="B210-microorganisms-07-00459">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Surewaard</surname>
<given-names>B.G.J.</given-names>
</name>
</person-group>
<article-title>Neutrophil evasion strategies by <italic>Streptococcus pneumoniae</italic> and <italic>Staphylococcus aureus</italic></article-title>
<source/>Cell Tissue Res.
          <year>2018</year>
<volume>371</volume>
<fpage>489</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-017-2737-2</pub-id>
<pub-id pub-id-type="pmid">29204747</pub-id>
</element-citation>
</ref>
<ref id="B211-microorganisms-07-00459">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Chavez</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Perez-Garcia</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Nino-Vega</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Mora-Montes</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Fungal Strategies to Evade the Host Immune Recognition</article-title>
<source/>J. Fungi (Basel)
          <year>2017</year>
<volume>3</volume>
<elocation-id>51</elocation-id>
<pub-id pub-id-type="doi">10.3390/jof3040051</pub-id>
<pub-id pub-id-type="pmid">29371567</pub-id>
</element-citation>
</ref>
<ref id="B212-microorganisms-07-00459">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chow</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Deo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Naderer</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Macrophage cell death in microbial infections</article-title>
<source/>Cell Microbiol.
          <year>2016</year>
<volume>18</volume>
<fpage>466</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1111/cmi.12573</pub-id>
<pub-id pub-id-type="pmid">26833712</pub-id>
</element-citation>
</ref>
<ref id="B213-microorganisms-07-00459">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricciardi</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Muthukrishnan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Masters</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ninomiya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title><italic>Staphylococcus aureus</italic> Evasion of Host Immunity in the Setting of Prosthetic Joint Infection: Biofilm and Beyond</article-title>
<source/>Curr. Rev. Musculoskelet Med.
          <year>2018</year>
<volume>9</volume>
<fpage>018</fpage>
<lpage>9501</lpage>
<pub-id pub-id-type="doi">10.1007/s12178-018-9501-4</pub-id>
<pub-id pub-id-type="pmid">29987645</pub-id>
</element-citation>
</ref>
<ref id="B214-microorganisms-07-00459">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byndloss</surname>
<given-names>M.X.</given-names>
</name>
<name>
<surname>Tsolis</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Chronic Bacterial Pathogens: Mechanisms of Persistence</article-title>
<source/>Microbiol. Spectr.
          <year>2016</year>
<volume>4</volume>
<fpage>0020</fpage>
<lpage>2015</lpage>
<pub-id pub-id-type="doi">10.1128/microbiolspec.VMBF-0020-2015</pub-id>
</element-citation>
</ref>
<ref id="B215-microorganisms-07-00459">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernal-Bayard</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ramos-Morales</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Molecular Mechanisms Used by <italic>Salmonella</italic> to Evade the Immune System</article-title>
<source/>Curr. Issues Mol. Biol.
          <year>2018</year>
<volume>25</volume>
<fpage>133</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.21775/cimb.025.133</pub-id>
<pub-id pub-id-type="pmid">28875943</pub-id>
</element-citation>
</ref>
<ref id="B216-microorganisms-07-00459">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roux</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gaudry</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dreyfuss</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>El-Benna</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>de Prost</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Denamur</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Saumon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ricard</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> impairs macrophage function and facilitates <italic>Pseudomonas aeruginosa</italic> pneumonia in rat</article-title>
<source/>Crit. Care Med.
          <year>2009</year>
<volume>37</volume>
<fpage>1062</fpage>
<lpage>1067</lpage>
<pub-id pub-id-type="doi">10.1097/CCM.0b013e31819629d2</pub-id>
<pub-id pub-id-type="pmid">19237918</pub-id>
</element-citation>
</ref>
<ref id="B217-microorganisms-07-00459">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sobue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bertolini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vickerman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nobile</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Dongari-Bagtzoglou</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title><italic>S. oralis</italic> activates the Efg1 filamentation pathway in <italic>C. albicans</italic> to promote cross-kingdom interactions and mucosal biofilms</article-title>
<source/>Virulence
          <year>2017</year>
<volume>8</volume>
<fpage>1602</fpage>
<lpage>1617</lpage>
<pub-id pub-id-type="doi">10.1080/21505594.2017.1326438</pub-id>
<pub-id pub-id-type="pmid">28481721</pub-id>
</element-citation>
</ref>
<ref id="B218-microorganisms-07-00459">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nash</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Fidel</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Noverr</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Morphology-Independent Virulence of <italic>Candida</italic> Species during Polymicrobial Intra-abdominal Infections with <italic>Staphylococcus aureus</italic></article-title>
<source/>Infect. Immun.
          <year>2015</year>
<volume>84</volume>
<fpage>90</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.01059-15</pub-id>
<pub-id pub-id-type="pmid">26483410</pub-id>
</element-citation>
</ref>
<ref id="B219-microorganisms-07-00459">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kean</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rajendran</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Haggarty</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Townsend</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Short</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Millington</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Candida albicans</italic> Mycofilms Support <italic>Staphylococcus aureus</italic> Colonization and Enhances Miconazole Resistance in Dual-Species Interactions</article-title>
<source/>Front. Microbiol.
          <year>2017</year>
<volume>8</volume>
<fpage>258</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.00258</pub-id>
<pub-id pub-id-type="pmid">28280487</pub-id>
</element-citation>
</ref>
<ref id="B220-microorganisms-07-00459">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holt</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Houston</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kjellerup</surname>
<given-names>B.V.</given-names>
</name>
</person-group>
<article-title>Role of extracellular polymeric substances in polymicrobial biofilm infections of <italic>Staphylococcus epidermidis</italic> and <italic>Candida albicans</italic> modelled in the nematode <italic>Caenorhabditis elegans</italic></article-title>
<source/>Pathog Dis.
          <year>2017</year>
<volume>75</volume>
<pub-id pub-id-type="doi">10.1093/femspd/ftx052</pub-id>
</element-citation>
</ref>
<ref id="B221-microorganisms-07-00459">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ader</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jawhara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nseir</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kipnis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vuotto</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chemani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sendid</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Poulain</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Guery</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Short term <italic>Candida albicans</italic> colonization reduces <italic>Pseudomonas aeruginosa</italic>-related lung injury and bacterial burden in a murine model</article-title>
<source/>Crit. Care
          <year>2011</year>
<volume>15</volume>
<fpage>R150</fpage>
<pub-id pub-id-type="doi">10.1186/cc10276</pub-id>
<pub-id pub-id-type="pmid">21689424</pub-id>
</element-citation>
</ref>
<ref id="B222-microorganisms-07-00459">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Medina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Coughlin</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>E.X.</given-names>
</name>
<name>
<surname>Lamont</surname>
<given-names>I.L.</given-names>
</name>
<name>
<surname>Reimmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hooper</surname>
<given-names>L.V.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>A.Y.</given-names>
</name>
</person-group>
<article-title><italic>Candida albicans</italic> Inhibits <italic>Pseudomonas aeruginosa</italic> Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis</article-title>
<source/>Plos Pathog.
          <year>2015</year>
<volume>11</volume>
<elocation-id>e1005129</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1005129</pub-id>
<pub-id pub-id-type="pmid">26313907</pub-id>
</element-citation>
</ref>
<ref id="B223-microorganisms-07-00459">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz</surname>
<given-names>P.I.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sobue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Biyikoglu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ricker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ikonomou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dongari-Bagtzoglou</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Synergistic interaction between <italic>Candida albicans</italic> and commensal oral streptococci in a novel in vitro mucosal model</article-title>
<source/>Infect. Immun.
          <year>2012</year>
<volume>80</volume>
<fpage>620</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.05896-11</pub-id>
<pub-id pub-id-type="pmid">22104105</pub-id>
</element-citation>
</ref>
<ref id="B224-microorganisms-07-00459">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nash</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Palmer</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Fidel</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Noverr</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Morphogenesis is not required for <italic>Candida albicans</italic>-<italic>Staphylococcus aureus</italic> intra-abdominal infection-mediated dissemination and lethal sepsis</article-title>
<source/>Infect. Immun.
          <year>2014</year>
<volume>82</volume>
<fpage>3426</fpage>
<lpage>3435</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.01746-14</pub-id>
<pub-id pub-id-type="pmid">24891104</pub-id>
</element-citation>
</ref>
<ref id="B225-microorganisms-07-00459">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ermolaeva</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Schumacher</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Insights from the worm: the <italic>C. elegans</italic> model for innate immunity</article-title>
<source/>Semin. Immunol.
          <year>2014</year>
<volume>26</volume>
<fpage>303</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="doi">10.1016/j.smim.2014.04.005</pub-id>
<pub-id pub-id-type="pmid">24856329</pub-id>
</element-citation>
</ref>
<ref id="B226-microorganisms-07-00459">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fehrmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jurk</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bertling</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Seidel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fegeler</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kehrel</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Heilmann</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Role for the fibrinogen-binding proteins coagulase and Efb in the <italic>Staphylococcus aureus</italic>-<italic>Candida</italic> interaction</article-title>
<source/>Int. J. Med. Microbiol.
          <year>2013</year>
<volume>303</volume>
<fpage>230</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijmm.2013.02.011</pub-id>
<pub-id pub-id-type="pmid">23684234</pub-id>
</element-citation>
</ref>
<ref id="B227-microorganisms-07-00459">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villena</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aguero</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Immunomodulatory and protective effect of probiotic <italic>Lactobacillus casei</italic> against <italic>Candida albicans</italic> infection in malnourished mice</article-title>
<source/>Microbiol. Immunol.
          <year>2011</year>
<volume>55</volume>
<fpage>434</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1111/j.1348-0421.2011.00334.x</pub-id>
<pub-id pub-id-type="pmid">21395664</pub-id>
</element-citation>
</ref>
<ref id="B228-microorganisms-07-00459">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zelante</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iannitti</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>De Luca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giovannini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pieraccini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zecchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>D’Angelo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Massi-Benedetti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fallarino</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22</article-title>
<source/>Immunity
          <year>2013</year>
<volume>39</volume>
<fpage>372</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.003</pub-id>
<pub-id pub-id-type="pmid">23973224</pub-id>
</element-citation>
</ref>
<ref id="B229-microorganisms-07-00459">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bork</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Beckmann</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The, C.U.B domain. A widespread module in developmentally regulated proteins</article-title>
<source/>J. Mol. Biol.
          <year>1993</year>
<volume>231</volume>
<fpage>539</fpage>
<lpage>545</lpage>
<pub-id pub-id-type="doi">10.1006/jmbi.1993.1305</pub-id>
<pub-id pub-id-type="pmid">8510165</pub-id>
</element-citation>
</ref>
<ref id="B230-microorganisms-07-00459">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arvanitis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mylonakis</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial Interactions</article-title>
<source/>Clin. Infect. Dis.
          <year>2015</year>
<volume>61</volume>
<fpage>S630</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1093/cid/civ816</pub-id>
<pub-id pub-id-type="pmid">26567281</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="microorganisms-07-00459-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Molecules and factors mediating the interaction between different <italic>Candida</italic> species and a variety of bacteria. <italic>Candida</italic> species include <italic>Candida (C.) albicans, Candida (C.) glabrata</italic> and <italic>Candida (C.) dubliniensis</italic>. Gram-positive bacteria are represented in lilac (<italic>Enterococcus (E.) faecalis</italic>) and Gram-negative bacteria in red (<italic>Pseudomonas (P.) aeruginosa, Escherichia (E.) coli, Acinetobacter (A.) baumannii, Aggregatibacter (A.) actinomycetemcomitans, Serratia (S.) marcescens, Bacteroides (B.) fragilis, Salmonella (S.) enterica, Klebsiella (K.) pneumoniae</italic>). Green arrows indicate supportive interactions and red lines represent inhibitory effects. If not indicated above the green arrows and red lines, the molecules mediating the interaction are currently unknown.</p>
</caption>
<graphic xlink:href="microorganisms-07-00459-g001"></graphic>
</fig>
<fig id="microorganisms-07-00459-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Molecules and factors mediating the interaction between <italic>Aspergillus</italic> species and bacteria. <italic>Aspergillus</italic> species include <italic>Aspergillus (A.) fumigatus</italic>, <italic>Aspergillus (A.) nidulans</italic>, <italic>Aspergillus (A.) niger</italic>, <italic>Aspergillus (A.) terreus</italic> and <italic>Aspergillus (A.) flavus</italic>. Gram-positive bacteria are represented in lilac (<italic>Streptomyces (S.) rapamycinicus</italic>) and Gram-negative bacteria in red (<italic>Klebsiella (K.) pneumoniae</italic>, <italic>Pseudomonas (P.) aeruginosa</italic>). Green arrows indicate supportive interactions and red lines represent inhibitory effects. If not indicated above the green arrows and red lines, the molecules mediating the interaction are currently unknown.</p>
</caption>
<graphic xlink:href="microorganisms-07-00459-g002"></graphic>
</fig>
<fig id="microorganisms-07-00459-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Molecules and factors mediating the interaction between <italic>Cryptococcus</italic> spp., <italic>Cladosporium</italic> spp., <italic>Rhizopus microsporus, Saccharomyces cerevisiae, Scedosporium aurantiacum</italic>, and different bacteria. Gram- positive bacteria are represented in lilac (<italic>Bacillus (B.) subtilis</italic>) and Gram-negative bacteria are represented in red (<italic>Pseudomonas (P.) aeruginosa, Klebsiella (K.) aerogenes</italic>). Green arrows indicate supportive interactions and red lines represent inhibitory effects. If not indicated above the green arrows and red lines, the molecules mediating the interaction are currently unknown.</p>
</caption>
<graphic xlink:href="microorganisms-07-00459-g003"></graphic>
</fig>
<table-wrap id="microorganisms-07-00459-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">microorganisms-07-00459-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Animal models used for studies of bacterial–fungal interactions and immune response.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Bacterial–Fungal Interaction</th>
<th align="center" colspan="2" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Host</th>
<th align="center" colspan="2" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Immune Response</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">References</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>In Vivo</italic> Model</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mortality</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cytokines/Chemokines/Molecules</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Effect</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="5" style="border-bottom:solid thin" valign="middle"><italic>Candida albicans</italic> and <italic>Pseudomonas aeruginosa</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rat</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Elevated pro-inflammatory cytokines: TNF-α, IFN-γ, IL-6</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Higher bacterial loads in the lungs; impaired macrophage function in the lungs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B216-microorganisms-07-00459">216</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">High mortality mostly due to protease activity of <italic>P. aeruginosa</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B1-microorganisms-07-00459">1</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">IL-22; IL-17 pathway; AMPs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Colonization by <italic>C. albicans</italic> leads to protection against <italic>P. aeruginosa-</italic>associated pneumonia; lower bacterial loads and decreased epithelial injury</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B99-microorganisms-07-00459">99</xref>,<xref ref-type="bibr" rid="B221-microorganisms-07-00459">221</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Factors secreted by <italic>C. albicans</italic> inhibit <italic>P. aeruginosa</italic> siderophores via cytotoxic molecules reducing the bacterial virulence</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B222-microorganisms-07-00459">222</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Zebrafish</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Elevated pro-inflammatory cytokine: IL-6; Elevated neutrophil chemoattractant: IL-8</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased <italic>C. albicans</italic>–mediated pathogenicity and virulence; increased inflammatory response; no excessive neutrophil infiltration</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B2-microorganisms-07-00459">2</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>C. albicans</italic> and <italic>Streptococcus</italic> spp.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Toll-like receptor (TLR)-2 signalling; cytokines IL-17C, CXCL1, MIP-2/CXCL2, TNF, IL-1α, IL-1β; neutrophil protein CD177, CD14, MMP8</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased <italic>C. albicans</italic>–mediated pathogenicity and virulence; increased inflammatory response; increased neutrophil infiltration; hypervirulent biofilms; hyphal gene <italic>EFG1</italic> required for robust mixed biofilms </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B113-microorganisms-07-00459">113</xref>,<xref ref-type="bibr" rid="B223-microorganisms-07-00459">223</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle"><italic>Candida</italic> spp. and <italic>Staphylococcus</italic> spp.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">IL-6; PGE2; IL-1β; TNF-α</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Yeast-to-hyphae transition of <italic>Candida</italic> does not influence dissemination and lethal sepsis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B218-microorganisms-07-00459">218</xref>,<xref ref-type="bibr" rid="B224-microorganisms-07-00459">224</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>C. elegans</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">C-type lectins; CUB domain containing factors; AMPs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased virulence of both species</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B220-microorganisms-07-00459">220</xref>,<xref ref-type="bibr" rid="B225-microorganisms-07-00459">225</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>Galleria mellonella</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Increased pathogenicity; <italic>Staphylococcus aureus</italic> helps <italic>C. albicans</italic> circumvent the IS, contributing to its persistence</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B219-microorganisms-07-00459">219</xref>,<xref ref-type="bibr" rid="B226-microorganisms-07-00459">226</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>C. albicans</italic> and <italic>Enterococcus faecalis</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>C. elegans</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Exposure to <italic>E. faecalis</italic> primes the IS to better cope with later exposure to <italic>C. albicans</italic>; hyphae are inhibited; reduced tissue damage</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B138-microorganisms-07-00459">138</xref>,<xref ref-type="bibr" rid="B140-microorganisms-07-00459">140</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>C. albicans</italic> and <italic>Escherichia coli</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Endotoxin mediating synergistic lethality</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Currently unknown</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B59-microorganisms-07-00459">59</xref>,<xref ref-type="bibr" rid="B60-microorganisms-07-00459">60</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>C. albicans</italic> and <italic>Lactobacillus</italic> spp. </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TNF-α; IFN-γ; IL-6; IL-10; IL-22</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bacterial treatment followed by <italic>C. albicans</italic> infection improved survival and resistance of the mouse</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B227-microorganisms-07-00459">227</xref>,<xref ref-type="bibr" rid="B228-microorganisms-07-00459">228</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>C. albicans</italic> and <italic>Acinetobacter baumannii</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>C. elegans</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↓</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>C. albicans</italic> pathogenicity is decreased; hyphae are inhibited; <italic>C. albicans</italic> proliferation in the gut is reduced</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B153-microorganisms-07-00459">153</xref>]</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>Aspergillus fumigatus</italic> and <italic>P. aeruginosa</italic></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<italic>G. mellonella</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Activation of mitogen-activated protein kinases (MAPKs) ERK and p38 </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No additive of the co-infection on inflammation; lack of synergistic inflammatory response; saturation of signaling pathways</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">[<xref ref-type="bibr" rid="B180-microorganisms-07-00459">180</xref>]</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The documented mortality of these bacterial–fungal interactions (BFI) is presented as higher (upward arrows) or lower (downward arrows) compared to the respective single infections. Cytokines, chemokines, and other molecules involved during the BFI, the immune system interaction and a brief description of the mechanisms are indicated. PGE2—prostaglandin E2; IS—immune system; CUB—C1s/C1r complement components, the embryonic sea urchin protein (Uegf), and bone morphogenetic protein 1 (Bmp1) [<xref ref-type="bibr" rid="B229-microorganisms-07-00459">229</xref>]; AMPs—antimicrobial peptides.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>